0001546380-24-000043 | 10-K | XBRL Viewer

Print Document

EQUITY - Stock Options, Additional Information (Details) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Cash received from exercise of stock options	$ 3,800,000	$ 2,300,000	$ 3,300,000
Options
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Weighted average fair value, granted (in dollars per share)	$ 15.25	$ 14.25
Intrinsic value of stock options exercised	$ 600,000
Compensation costs not yet recognized, net	$ 9,400,000
Expected weighted average period for unrecognized compensation cost (in years)	2 years

IMPAIRMENT, RESTRUCTURING AND OTHER - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring reserves classified as long-term	$ 5.7
Restructuring Incurred Cost, Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag	false	false	false
Impairment of intangible assets			$ 35.3
Impairment of goodwill		$ 10.3
Inventory write-down charges			$ 120.9
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]			Impairment, restructuring and other
Operating Expenses, Impairment, Restructuring And Other
Restructuring Cost and Reserve [Line Items]
Gain on resolution of dispute	$ 12.1
Restructuring Initiative Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs	89.4	229.0	$ 65.2
U.S. Consumer
Restructuring Cost and Reserve [Line Items]
Impairment of goodwill		0.0
U.S. Consumer \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs	11.3	16.3	9.7
U.S. Consumer \| Operating Expenses, Impairment, Restructuring And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs	1.5	7.7	11.9
U.S. Consumer \| Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	58.3
Hawthorne
Restructuring Cost and Reserve [Line Items]
Goodwill and intangible asset impairments		127.9	632.4
Impairment of intangible assets		117.7	110.0
Impairment of goodwill		0.0	522.4
Hawthorne \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs	71.8	168.5	27.1
Hawthorne \| Operating Expenses, Impairment, Restructuring And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs	1.0	20.7	8.1
Hawthorne \| Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	297.2
Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs	1.1	0.8	0.7
Impairment of goodwill		10.3
Other \| Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	2.9
Corporate Segment
Restructuring Cost and Reserve [Line Items]
Restructuring costs	2.4	$ 14.9	$ 7.7
Corporate Segment \| Restructuring Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 25.1

CONTINGENCIES	12 Months Ended
CONTINGENCIES	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Management regularly evaluates the Company’s contingencies, including various judicial and administrative proceedings and claims arising in the ordinary course of business, including product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals are adequate, both individually and in the aggregate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. Regulatory Matters At September 30, 2024, the Company had recorded liabilities of $2.6 for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material. Other The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. The Company has not recorded any accruals in its consolidated financial statements as the likelihood of a loss from these cases is not probable at this time. The Company does not believe a reasonably possible loss would be material to the Company’s financial condition, results of operations or cash flows. In addition, the Company does not believe the ultimate resolution of these cases will have a material adverse effect on the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows. On June 6, 2024, a purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03132) on behalf of a proposed class of purchasers of Common Shares between November 3, 2021, and August 1, 2023. On July 26, 2024, another purported shareholder filed a lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03766) on behalf of a proposed class of purchasers of Common Shares between June 2, 2021, and August 1, 2023. These lawsuits, which will likely be consolidated with any subsequently filed lawsuits alleging similar facts, assert claims under Section 10(b), Rule 10b-5 and Section 20(a) of the Securities Exchange Act against the Company and certain of its current and former officers based on alleged misstatements about the Company’s inventories, sales and business prospects. The actions seek, among other things, unspecified monetary damages, reasonable costs and expenses and equitable/injunctive or other relief as deemed appropriate by the Court. The Company believes that the claims asserted are without merit and intends to vigorously defend the actions. On July 3, 2024, a purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03636), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On July 30, 2024, a second purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No.1:24-cv-00402), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On August 23, 2024, a third purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-03880), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 9, 2024, a fourth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0193), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On September 26, 2024, a fifth purported shareholder filed a shareholder derivative lawsuit in the Union County (Ohio) Court of Common Pleas (Case No. 24CV0203), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 19, 2024, a sixth purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04180), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. On November 22, 2024, a seventh purported shareholder filed a shareholder derivative lawsuit in the United States District Court for the Southern District of Ohio (Case No. 2:24-cv-04190), purportedly on behalf of the Company against certain of the Company’s current and former officers and directors. The federal lawsuits will likely be consolidated with one another, along with any subsequently filed federal lawsuits alleging similar facts, and the state court lawsuits will likely be consolidated with one another, along with any subsequently filed state lawsuits alleging similar facts. All of the lawsuits include allegations that generally mirror those asserted in the securities lawsuits described above and assert claims for breaches of fiduciary duties and unjust enrichment, as well as abuse of control, gross mismanagement, and waste of corporate assets. The federal lawsuits also assert claims under Section 10(b), Rule 10b-5, Section 14(a), Rule 14a-9, and Section 20(a) of the Securities Exchange Act, and contribution under Sections 10(b) and 21D of the Securities Exchange Act. The actions seek a judgment in favor of the Company for damages in an unspecified amount, disgorgement, interest, and costs and expenses, including attorneys’ and experts’ fees. The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to have a material effect on the Company’s financial condition, results of operations or cash flows.

- Definition

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-20/tableOfContent

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-30/tableOfContent

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483049/450-30-50-1

+ Details

INVESTMENT IN UNCONSOLIDATED AFFILIATES (Details) - USD ($) $ in Millions		12 Months Ended
	Nov. 07, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2020
Investments in and Advances to Affiliates [Line Items]
Payments to acquire equity interest		$ 21.4	$ 0.0	$ 0.0
Investment in unconsolidated affiliates		45.2	91.9
Equity in loss of unconsolidated affiliates		(68.1)	(101.1)	$ (12.9)
Pre-tax impairment charges		$ 61.9	$ 94.7
Bonnie Plants, LLC
Investments in and Advances to Affiliates [Line Items]
Percent ownership	50.00%				45.00%	50.00%
Payments to acquire equity interest	$ 21.4
Ownership percentage increase (decrease)	5.00%

- Definition

This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.

+ References + Details

- Definition

Amount of income (loss) for proportionate share of equity method investee's income (loss).

+ References + Details

GOODWILL AND INTANGIBLE ASSETS, NET - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	$ 323.9	$ 323.9
Total intangible assets, net	418.8	436.7
Intangible Assets [Line Items]
Total finite-lived intangible assets, net	94.9	112.8
Trade names
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	168.2	168.2
Roundup® marketing agreement amendment
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	155.7	155.7
Trade names
Intangible Assets [Line Items]
Gross Carrying Amount	325.8	322.4
Accumulated Amortization/ Impairment Charges	(272.8)	(260.7)
Total finite-lived intangible assets, net	53.0	61.7
Customer relationships
Intangible Assets [Line Items]
Gross Carrying Amount	253.1	251.5
Accumulated Amortization/ Impairment Charges	(223.9)	(216.1)
Total finite-lived intangible assets, net	29.2	35.4
Technology
Intangible Assets [Line Items]
Gross Carrying Amount	50.2	50.1
Accumulated Amortization/ Impairment Charges	(45.5)	(44.5)
Total finite-lived intangible assets, net	4.7	5.6
Other
Intangible Assets [Line Items]
Gross Carrying Amount	35.0	34.9
Accumulated Amortization/ Impairment Charges	(27.0)	(24.8)
Total finite-lived intangible assets, net	$ 8.0	$ 10.1

ACQUISITIONS AND INVESTMENTS - Cyco (Details) - USD ($) $ in Millions	Apr. 28, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Business Acquisition [Line Items]
Goodwill		$ 243.9	$ 243.9	$ 254.0
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 0.0	$ 0.0
Cyco
Business Acquisition [Line Items]
Maximum payout	$ 10.0
Cyco \| Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	37.3
Contingent consideration	3.1
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory And Other Current Assets	1.3
Finite-lived intangible assets acquired	10.5
Goodwill	$ 25.6
Cyco \| Hawthorne \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Cyco \| Hawthorne \| Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	25 years

SEGMENT INFORMATION

12 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

SEGMENT INFORMATION

The Company divides its operations into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of the Company’s consumer lawn and garden business in the United States. Hawthorne consists of the Company’s indoor and hydroponic gardening business. Other primarily consists of the Company’s consumer lawn and garden business in Canada. This identification of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the reportable business segments.

The performance of each reportable segment is evaluated based on several factors, including income (loss) before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”). Senior management uses Segment Profit (Loss) to evaluate segment performance because the Company believes this measure is indicative of performance trends and the overall earnings potential of each segment.

The following tables present financial information for the Company’s reportable segments for the periods indicated:


	Year Ended September 30,
	2024		2023		2022

Net Sales:
U.S. Consumer	$	3,013.7	$	2,843.7	$	2,928.8
Hawthorne	294.7		467.3		716.2
Other	244.3		240.3		279.1
Consolidated	$	3,552.7	$	3,551.3	$	3,924.1
Segment Profit (Loss):
U.S. Consumer	$	498.0	$	454.1	$	568.6
Hawthorne	(14.2)		(48.1)		(21.1)
Other	4.7		12.4		20.2
Total Segment Profit	488.5		418.4		567.7
Corporate	(117.7)		(101.6)		(112.4)
Intangible asset amortization	(15.7)		(25.2)		(37.1)

Impairment, restructuring and other	(146.3)		(466.0)		(852.2)
Equity in loss of unconsolidated affiliates	(68.1)		(101.1)		(12.9)

Interest expense	(158.8)		(178.1)		(118.1)
Other non-operating income (expense), net	(5.5)		0.3		6.9
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)
Depreciation and amortization:
U.S. Consumer	$	56.2	$	58.2	$	55.8
Hawthorne	16.7		25.8		34.8
Other	5.9		5.6		7.0
Corporate	1.8		2.9		7.6
	$	80.6	$	92.5	$	105.2
Capital expenditures:
U.S. Consumer	$	81.5	$	79.6	$	97.4
Hawthorne	—		8.5		12.4
Other	2.5		4.7		3.7
	$	84.0	$	92.8	$	113.5


	September 30,
	2024		2023

Total assets:
U.S. Consumer	$	2,022.7	$	2,296.2
Hawthorne	387.3		581.6
Other	189.3		189.8
Corporate	272.6		346.1

Consolidated	$	2,871.9	$	3,413.7

The following table presents net sales by product category for the periods indicated:


	Year Ended September 30,
	2024		2023		2022

U.S. Consumer:
Growing media and mulch	$	1,310.6	$	1,223.7	$	1,192.6
Lawn care	929.6		897.4		973.6
Controls	414.6		362.9		382.2
Roundup® marketing agreement	162.4		138.7		132.3
Other, primarily gardening	196.5		221.0		248.1
Hawthorne:
Lighting	108.2		165.9		200.0
Nutrients	87.2		105.3		148.0
Growing media	37.3		67.5		119.0
Growing environment	27.7		72.5		143.7
Other, primarily hardware	34.3		56.1		105.5
Other:
Growing media	91.3		93.0		96.6
Lawn care	80.2		75.8		92.9
Other, primarily gardening and controls	72.8		71.5		89.6
Total net sales	$	3,552.7	$	3,551.3	$	3,924.1

The Company’s two largest customers accounted for the following percentages of net sales for the fiscal years ended September 30:


	Percentage of Net Sales
	2024		2023		2022
The Home Depot	30	%	29	%	28	%
Lowe’s	18	%	18	%	15	%

Accounts receivable for these two largest customers as a percentage of consolidated accounts receivable were 18% and 41% as of September 30, 2024 and 2023, respectively. The decrease was due to the impact of accounts receivable sold under the Master Receivables Purchase Agreement.

The following table presents net sales by geographic area for the periods indicated:


	Year Ended September 30,
	2024		2023		2022

Net sales:
United States	$	3,247.8	$	3,209.5	$	3,554.6
International	304.9		341.8		369.5
	$	3,552.7	$	3,551.3	$	3,924.1

Other than the United States, no other country accounted for more than 10% of the Company’s net sales for any period presented above.

The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area:


	September 30,
	2024		2023

Long-lived assets:
United States	$	630.5	$	644.4
International	73.9		78.7
	$	704.4	$	723.1

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

+ Details

DEBT - Components of Long-Term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Debt Instrument [Line Items]
Total debt	$ 2,242.8	$ 2,630.6
Finance lease obligations	17.8	16.9
Less current portions	52.6	52.3
Long-term debt	2,174.2	2,557.4
Credit Facilities \| Revolving loans
Debt Instrument [Line Items]
Total debt	0.0	88.3
Credit Facilities \| Term loans
Debt Instrument [Line Items]
Total debt	625.0	925.0
Senior Notes \| Senior Notes due 2031 – 4.000%
Debt Instrument [Line Items]
Total debt	$ 500.0	$ 500.0
Interest rate (percent)	4.00%	4.00%		4.00%
Senior Notes \| Senior Notes due 2032 – 4.375%
Debt Instrument [Line Items]
Total debt	$ 400.0	$ 400.0
Interest rate (percent)	4.375%	4.375%	4.375%
Senior Notes \| Senior Notes - 4.500%
Debt Instrument [Line Items]
Total debt	$ 450.0	$ 450.0
Interest rate (percent)	4.50%	4.50%			4.50%
Senior Notes \| Senior Notes due 2026 – 5.250%
Debt Instrument [Line Items]
Total debt	$ 250.0	$ 250.0
Interest rate (percent)	5.25%	5.25%				5.25%
Other
Debt Instrument [Line Items]
Total debt	$ 0.0	$ 0.4
Long-term Debt
Debt Instrument [Line Items]
Less unamortized debt issuance costs	$ 16.0	$ 20.9

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring Basis

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:


		2024				2023
	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	51.2	$	51.2	$	1.2	$	1.2




Other
Investment securities in non-qualified retirement plan assets	Level 1	32.4		32.4		36.3		36.3

Convertible debt investments	Level 3	45.8		45.8		85.8		85.8

Liabilities




Debt instruments
Credit facilities – revolving loans	Level 2	—		—		88.3		88.3
Credit facilities – term loans	Level 2	625.0		625.0		925.0		925.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		456.3		500.0		380.0
Senior Notes due 2032 – 4.375%	Level 2	400.0		370.0		400.0		304.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		432.0		450.0		366.8
Senior Notes due 2026 – 5.250%	Level 2	250.0		248.8		250.0		233.1



Other debt	Level 2	—		—		0.4		0.4

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.


	Year Ended September 30,
	2024		2023
Fair value at beginning of year	$	85.8	$	117.0

Total realized / unrealized gains (losses) included in net earnings	(64.2)		(97.6)
Total realized / unrealized gains / losses included in / reclassified from OCI	24.2		66.4
Fair value at end of year	$	45.8	$	85.8

Debt Securities, Available-for-Sale, Allowance for Credit Loss

A progression of the allowance for expected credit losses on convertible debt investments is shown below:


	Year Ended September 30,
	2024		2023
Balance at beginning of year	$	101.3	$	—
Provision for expected credit losses on securities with no previous allowance	—		101.3

Reductions for securities intended to be sold / exchanged	(99.4)		—
Balance at end of year	$	1.9	$	101.3

- Definition

Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.

+ References + Details

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

EQUITY - Schedule of Valuation Assumptions (Details)	12 Months Ended
EQUITY - Schedule of Valuation Assumptions (Details)	Sep. 30, 2024
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	38.80%
Risk-free interest rate	4.70%
Expected dividend yield	4.10%
Expected life	6 years 1 month 6 days
Performance-Based Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	36.60%
Risk-free interest rate	4.50%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

DEBT

12 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

DEBT

The components of debt are as follows:


	September 30,
	2024		2023

Credit Facilities:
Revolving loans	$	—	$	88.3
Term loans	625.0		925.0
Senior Notes due 2031 – 4.000%	500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0


Finance lease obligations	17.8		16.9
Other	—		0.4
Total debt	2,242.8		2,630.6
Less current portions	52.6		52.3
Less unamortized debt issuance costs	16.0		20.9
Long-term debt	$	2,174.2	$	2,557.4

The Company’s aggregate scheduled maturities of debt by fiscal year, excluding finance lease obligations, are as follows:


2025	$	50.0
2026	50.0
2027	775.0
2028	—
2029	—
Thereafter	1,350.0
	$	2,225.0

Credit Facilities

On April 8, 2022, the Company entered into the Sixth A&R Credit Agreement, providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,500.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $1,000.0. The Sixth A&R Credit Agreement will terminate on April 8, 2027. The Sixth A&R Credit Facilities are available for the issuance of letters of credit up to $100.0. The terms of the Sixth A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default.

Under the terms of the Sixth A&R Credit Agreement, loans bear interest, at the Company’s election, at a rate per annum equal to either (i) the Alternate Base Rate plus the Applicable Spread (each, as defined in the Sixth A&R Credit Agreement) or (ii) the Adjusted Term SOFR Rate for the Interest Period in effect for such borrowing plus the Applicable Spread (all as defined in the Sixth A&R Credit Agreement). Swingline Loans bear interest at the applicable Swingline Rate set forth in the Sixth A&R Credit Agreement. Interest rates for other select non-U.S. dollar borrowings, including borrowings denominated in euro, Pounds Sterling and Canadian dollars, are based on separate interest rate indices, as set forth in the Sixth A&R Credit Agreement.

On June 8, 2022, the Company entered into Amendment No. 1 to the Sixth A&R Credit Agreement. Amendment No. 1 increased the maximum permitted leverage ratio for the quarterly leverage covenant until April 1, 2024. Amendment No. 1 also increased the interest rate applicable to borrowings under the revolving credit facility by 35 bps and the term loan facility by 50 bps, and increased the annual facility fee rate on the revolving credit facility by 15 bps, in each case, when the Company’s quarterly-tested leverage ratio exceeded 4.75.

On July 31, 2023, the Company entered into Amendment No. 2 to the Sixth A&R Credit Agreement. Amendment No. 2 (i) reduces the revolving loan commitments by $250.0; (ii) increases the maximum permitted leverage ratio for the quarterly leverage covenant during the Leverage Adjustment Period; (iii) replaces the interest coverage covenant with a fixed charge coverage covenant; (iv) increases the interest rate applicable to borrowings under the revolving credit facility and the term loan facility by 25 bps for each existing pricing tier and adds a pricing tier applicable to periods when the leverage ratio exceeds 6.00; (v) limits the amount of certain incremental investments, loans and advances to $25.0 during the Leverage Adjustment Period; and (vi) adds the Company’s intellectual property (subject to certain exceptions) as collateral to secure its obligations under the Sixth A&R Credit Agreement. Additionally, Amendment No. 2 limits the Company’s ability to declare or pay any discretionary dividends, distributions or other restricted payments during the Leverage Adjustment Period to only the payment of (i) regularly scheduled cash dividends to holders of its Common Shares in an aggregate amount not to exceed $225.0 per fiscal year and (ii) other dividends, distributions or restricted payments in an aggregate amount not to exceed $25.0. Amendment No. 2 also subjects the Company’s ability to make certain investments to pro forma compliance with certain leverage levels specified in Amendment No. 2. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement is secured by (i) a perfected first priority security interest in all of the accounts receivable, inventory, equipment and intellectual property (subject to certain exceptions) of Scotts Miracle-Gro and certain of its domestic subsidiaries and (ii) the pledge of all of the capital stock of certain of Scotts Miracle-Gro’s domestic subsidiaries and a portion of the capital stock of certain of its foreign subsidiaries.

At September 30, 2024, the Company had letters of credit outstanding in the aggregate principal amount of $83.0, and had $1,167.0 of borrowing availability under the Sixth A&R Credit Agreement. The weighted average interest rates on average borrowings under the credit facilities, excluding the impact of interest rate swaps, were 9.1%, 7.6% and 2.8% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

During fiscal 2024, the Company used available cash on hand to make repayments on the term loan of the Sixth A&R Credit Agreement in the amount of $250.0, which was applied to the outstanding principal amount.

The Sixth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio determined as of the end of each of its fiscal quarters calculated as average total indebtedness, divided by the Company’s Adjusted EBITDA. Pursuant to Amendment No. 2, the maximum permitted leverage ratio is (i) 6.00 for the fourth quarter of fiscal 2024, (ii) 5.50 for the first quarter of fiscal 2025, (iii) 5.25 for the second quarter of fiscal 2025, (iv) 5.00 for the third quarter of fiscal 2025, (v) 4.75 for the fourth quarter of fiscal 2025 and (vi) 4.50 for the first quarter of fiscal 2026 and thereafter. The Company’s leverage ratio was 4.86 at September 30, 2024. Pursuant to Amendment No. 2, the Sixth A&R Credit Agreement also contains an affirmative covenant regarding the Company’s fixed charge coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA minus capital expenditures and expense for taxes paid in cash, divided by the sum of interest expense plus restricted payments, as described in Amendment No. 2. The minimum required fixed charge coverage ratio is 1.00. The Company’s fixed charge coverage ratio was 1.27 for the twelve months ended September 30, 2024.

As of September 30, 2024, the Company was in compliance with all applicable covenants in the agreements governing its debt. Based on the Company’s projections of its financial performance for the twelve-month period subsequent to the date of the filing of this Form 10-K, the Company expects to remain in compliance with the financial covenants under the Sixth A&R Credit Agreement. However, the Company’s assessment of its ability to meet its future obligations is inherently subjective, judgment-based, and susceptible to change based on future events. A covenant violation may result in an event of default. Such a default would allow the lenders under the Sixth A&R Credit Agreement to accelerate the maturity of the indebtedness thereunder and would also implicate cross-default provisions under the Senior Notes, and cause the Senior Notes to become due and payable at that time. As of September 30, 2024, the Company’s indebtedness under the Sixth A&R Credit Agreement and Senior Notes was $2,225.0. The Company does not have sufficient cash on hand or available liquidity that can be utilized to repay these outstanding amounts in the event of default.

As part of its contingency planning to address potential future circumstances that could result in noncompliance, the Company has contemplated alternative plans including additional restructuring activities to reduce operating expenses and certain cash management strategies that are within the Company’s control. Additionally, the Company has contemplated alternative plans that are subject to market conditions and not in the Company’s control, including, among others, discussions with its lenders to amend the terms of its financial covenants under the Sixth A&R Credit Agreement and generating cash by completing other financing transactions, which may include issuing equity. There is no assurance that the Company will be successful in implementing these alternative plans.

Senior Notes

On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes due 2026. The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029. The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031. The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032. The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes.

The Senior Notes contain an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA divided by interest expense excluding costs related to refinancings. The minimum required interest coverage ratio is 2.00. The Company’s interest coverage ratio was 3.57 for the twelve months ended September 30, 2024.

Receivables Facility

On April 7, 2017, the Company entered into the Receivables Facility, under which the Company could sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers subject to agreeing to repurchase the receivables on a weekly basis. The eligible accounts receivable consisted of accounts receivable generated by sales to three specified customers. The eligible amount of customer accounts receivables which could be sold under the Receivables Facility was $400.0. The Receivables Facility expired on August 18, 2023. The sale of receivables under the Receivables Facility was accounted for as short-term debt and the Company continued to carry the receivables on its Consolidated Balance Sheets, primarily as a result of its requirement to repurchase receivables sold.

Interest Rate Swap Agreements

The Company enters into interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of September 30, 2024 and 2023 had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0, respectively. During fiscal 2024, the Company terminated an interest rate swap agreement in exchange for a cash payment of $11.0. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at September 30, 2024 are shown in the table below:


Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate




150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

Weighted Average Interest Rate

The weighted average interest rates on the Company’s debt, including the impact of interest rate swaps, were 5.8%, 5.4% and 3.6% for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

EQUITY (Tables)

12 Months Ended

Sep. 30, 2024

Equity [Abstract]

Schedule of Authorized and Issued Shares

Authorized and issued shares consisted of the following (in millions):


	September 30,
	2024	2023

Preferred shares, no par value:
Authorized	0.2 shares	0.2 shares
Issued	0.0 shares	0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized	100.0 shares	100.0 shares
Issued	68.1 shares	68.1 shares

Schedule of Accumulated Other Comprehensive Loss

Changes in AOCL by component were as follows for the fiscal years ended September 30:


	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Loss On Securities		Pension and Other Post- Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2021	$	(1.7)	$	10.2	$	(2.3)	$	(72.5)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(27.2)		40.1		(102.0)		(7.3)		(96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.1)		—		11.7		2.6
Income tax benefit (expense)	—		(7.9)		24.6		(1.1)		15.6
Net current period other comprehensive income (loss)	(27.2)		23.1		(77.4)		3.3		(78.2)
Balance at September 30, 2022	(28.9)		33.3		(79.7)		(69.3)		(144.6)
Other comprehensive income (loss) before reclassifications	7.0		5.6		(34.9)		(2.5)		(24.8)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(23.3)		101.3		(1.6)		76.4
Income tax benefit (expense)	—		4.5		(25.3)		1.0		(19.8)
Net current period other comprehensive income (loss)	7.0		(13.2)		41.1		(3.1)		31.8
Balance at September 30, 2023	(21.9)		20.1		(38.6)		(72.4)		(112.8)
Other comprehensive income (loss) before reclassifications	0.6		(10.6)		(40.4)		(2.8)		(53.2)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.7)		64.6		(2.7)		52.2
Income tax benefit (expense)	—		5.1		—		1.4		6.5
Net current period other comprehensive income (loss)	0.6		(15.2)		24.2		(4.1)		5.5
Balance at September 30, 2024	$	(21.3)	$	4.9	$	(14.4)	$	(76.5)	$	(107.3)

The sum of the components may not equal due to rounding.

Schedule of Share-Based Compensation

Total share-based compensation was as follows for each of the periods indicated:


	Year Ended September 30,
	2024		2023		2022

Share-based compensation	$	79.8	$	68.1	$	30.3
Related tax benefit recognized	14.8		15.6		4.9

Schedule of Aggregate Stock Option Activity

Stock option activity was as follows:


	No. of Options	Wtd. Avg. Exercise Price		Wtd Avg Remaining Life	Aggregate Intrinsic Value
Awards outstanding at September 30, 2023	1,191,183	$	76.64	6.6 years
Granted	1,356,698	53.75
Exercised	(35,027)	58.52
Forfeited	(135,182)	55.69
Awards outstanding at September 30, 2024	2,377,672	65.03		7.5 years	$	71.4
Exercisable	493,832	108.97		2.6 years	8.9

Schedule of Share-Based Awards Granted

The weighted average assumptions used in the estimation of fair value for awards granted in fiscal 2024 are as follows:



Expected volatility	38.8	%
Risk-free interest rate	4.7	%
Expected dividend yield	4.1	%
Expected life	6.1 years

Details of the assumptions used in the estimation of fair value for these awards are as follows:



Expected volatility	36.6	%
Risk-free interest rate	4.5	%

Schedule of Restricted Share-Based Award Activity

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit








Awards outstanding at September 30, 2023	611,838	$	89.10
Granted	363,264	55.12
Vested	(77,826)	182.87
Forfeited	(130,892)	59.40
Awards outstanding at September 30, 2024	766,384	68.54

Schedule of Performance-Based Award Activity

Performance-based award activity was as follows (based on target award amounts):


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit








Awards outstanding at September 30, 2023	544,790	$	76.85
Granted	240,677	74.57
Vested (a)	(181,791)	59.88
Forfeited	(194,246)	65.89
Awards outstanding at September 30, 2024	409,430	86.61

(a)Vested at a weighted average of 100% of the target performance share units granted.

- Definition

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-4

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-5

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481142/505-10-45-2

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-10

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

+ Details

DEBT - Senior Notes (Details) - Senior Notes - USD ($) $ in Millions	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Sep. 30, 2024	Sep. 30, 2023	Dec. 15, 2016
Debt Instrument [Line Items]
Debt Instrument, Covenant, Interest Coverage Ratio, Minimum				2.00
Debt Instrument, Covenant, Interest Coverage Ratio				3.57
Senior Notes due 2026 – 5.250%
Debt Instrument [Line Items]
Interest rate (percent)				5.25%	5.25%	5.25%
Face amount of debt						$ 250.0
Senior Notes - 4.500%
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt			$ 450.0
Interest rate (percent)			4.50%	4.50%	4.50%
Senior Notes due 2031 – 4.000%
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt		$ 500.0
Interest rate (percent)		4.00%		4.00%	4.00%
Senior Notes due 2032 – 4.375%
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt	$ 400.0
Interest rate (percent)	4.375%			4.375%	4.375%

LEASES - (Supplemental Balance Sheet Information Schedule) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Operating lease right-of-use assets	$ 265.4	$ 262.6
Current lease liabilities	75.3	76.4
Non-current operating lease liabilities	215.8	220.1
Total operating lease liabilities	291.1	296.5
Finance lease right-of-use assets	15.2	14.5
Finance lease current lease liabilities	2.6	1.9
Finance lease non-current lease liabilities	15.2	15.0
Total finance lease liabilities	$ 17.8	$ 16.9
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets	Other assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other Liabilities, Current	Other Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, plant and equipment, net	Property, plant and equipment, net
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Current portion of debt	Current portion of debt
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt	Long-term debt

INCOME TAXES - Provision (Benefit) For Income Taxes Allocated to Continuing Operation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Current:
Federal	$ 2.4	$ 3.7	$ 22.8
State	2.5	0.6	9.3
Foreign	(5.3)	1.6	8.7
Total Current	(0.4)	5.9	40.8
Deferred:
Federal	11.6	(62.1)	(125.5)
State	(3.8)	(5.2)	(23.3)
Foreign	3.9	(11.8)	(12.6)
Total Deferred	11.7	(79.1)	(161.4)
Provision (benefit) for income taxes	$ 11.3	$ (73.2)	$ (120.6)

LEASES - (Components of Lease Cost Schedule) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating lease cost	$ 85.8	$ 92.3	$ 86.7
Variable lease cost	30.3	28.6	35.9
Amortization of right-of-use assets	2.6	3.0	6.4
Interest on lease liabilities	0.8	0.8	1.2
Total finance lease cost	3.4	3.8	7.6
Operating lease amortization of ROU assets	70.4	81.0	75.3
Short-term lease expense	$ 6.1	$ 6.6	$ 19.1

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS (Tables)

12 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Detail of Certain Financial Statement Accounts

The following presents detail regarding certain financial statement accounts:


	September 30,
	2024		2023

INVENTORIES:
Raw materials	$	256.8	$	272.5
Finished goods	246.6		506.2
Work-in-progress	84.1		101.6
	$	587.5	$	880.3
PROPERTY, PLANT AND EQUIPMENT, NET:
Machinery and equipment	$	683.6	$	651.7
Buildings	305.8		277.1
Land and improvements	152.9		149.0
Software	107.2		109.9
Construction in progress	78.7		104.6
Furniture and fixtures	62.6		62.3
Finance leases	24.1		21.1

	1,414.9		1,375.7
Less: accumulated depreciation	(805.4)		(765.4)
	$	609.5	$	610.3
OTHER ASSETS:
Operating lease right-of-use assets	$	265.4	$	262.6
Net deferred tax assets	191.3		189.8
Accrued pension, postretirement and executive retirement assets	62.7		64.1
Convertible debt investments	45.8		85.8


Other	8.9		30.8
	$	574.1	$	633.1


	September 30,
	2024		2023

OTHER CURRENT LIABILITIES:
Advertising and promotional accruals	$	131.2	$	143.0
Current operating lease liabilities	75.3		76.4
Payroll and other compensation accruals	72.0		51.2

Accrued interest	29.4		31.9
Accrued taxes	16.7		28.5



Other	118.4		119.2
	$	443.0	$	450.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	$	215.8	$	220.1
Accrued pension, postretirement and executive retirement liabilities	73.0		76.7
Net deferred tax liabilities	7.0		1.1

Other	42.2		52.0
	$	338.0	$	349.9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia.

The Company’s North America consumer lawn and garden business is highly seasonal, with approximately 75% of its annual net sales occurring in the second and third fiscal quarters. The Company’s Hawthorne segment is also impacted by seasonal sales patterns for certain product categories due to the timing of growing patterns in North America during the second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during the third and fourth fiscal quarters.

Organization and Basis of Presentation

The Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

Advertising

Advertising costs incurred during the year are expensed to interim periods in relation to revenues. Advertising costs, except for external production costs, are generally expensed within the fiscal year in which such costs are incurred. External production costs for advertising programs are deferred until the period in which the advertising is first aired, and deferrals of these costs were not material at September 30, 2024 and 2023. On September 4, 2024, the Company issued 0.3 million restricted shares to a vendor in exchange for advertising services that will be performed during fiscal 2025. As of September 30, 2024, deferred advertising costs associated with the issuance of these restricted shares were $20.0. Advertising expenses were $141.0, $123.7 and $120.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Research and Development

Costs associated with research and development are generally charged to expense as incurred. Expenses for fiscal 2024, fiscal 2023 and fiscal 2022 were $34.6, $35.7 and $45.3, respectively, including product registration costs of $9.0, $12.4 and $13.0, respectively.

Environmental Costs

The Company recognizes environmental liabilities when conditions requiring remediation are probable and the amounts can be reasonably estimated. Expenditures which extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. Environmental liabilities are not discounted or reduced for possible recoveries from insurance carriers.

Earnings per Common Share

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding each period. Diluted income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus all dilutive potential common shares (stock options, restricted stock units, deferred stock units and performance-based award units) outstanding each period.

Share-Based Compensation Awards

Scotts Miracle-Gro grants share-based awards annually to officers and certain other associates and to the non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based award units. Performance-based award units are subject to performance and service conditions, and certain awards contain a market condition based on the Company’s total shareholder return relative to a Company selected peer group. All of these share-based awards have been made under plans approved by the shareholders. The fair value of awards is expensed over the requisite service period which is typically the vesting period, generally three years for awards granted to officers and other associates and one year for awards granted to non-employee directors.

For restricted stock units, deferred stock units and performance-based award units that do not contain a market condition, the fair value of each award is estimated on the grant date based on the current market price of the Common Shares. For performance-based award units that contain a market condition, the fair value of each award is estimated using a Monte Carlo simulation model. Expected market price volatility is based on historical volatility specific to the Common Shares. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The grant date fair value of stock option awards is estimated using a binomial model. Expected market price volatility is based on implied volatilities from traded options on Common Shares and historical volatility specific to the Common Shares. Historical data, including demographic factors impacting historical exercise behavior, is used to estimate stock option exercises and employee terminations within the valuation model. The risk-free rate for periods within the contractual life of the stock option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of stock options is based on historical experience and expectations for grants outstanding.

Vesting of performance-based award units depends on service and achievement of specified performance targets. Based on the extent to which the targets are achieved, vested shares may range from 0% to 325% of the target award amount. For performance-based award units that do not contain a market condition, the total amount of compensation expense recognized reflects management’s assessment of the probability that performance goals will be achieved. A cumulative adjustment is recognized to compensation expense in the current period to reflect any changes in the probability of achievement of performance goals. For performance-based award units that contain a market condition, compensation expense is recognized regardless of the extent to which the targets are achieved.

Restricted stock units, deferred stock units and performance-based award units receive dividend equivalents equal to the cash dividends earned during the vesting period that are only paid out upon vesting. Share-based award units are generally forfeited if a holder terminates employment or service with the Company prior to the vesting date, except in cases where associates are eligible for accelerated vesting based on having satisfied retirement requirements relating to age and years of service. The Company estimates that 15% of its share-based awards will be forfeited based on an analysis of historical trends. The Company evaluates the estimated forfeiture rate on an annual basis and makes adjustments as appropriate. Stock options have exercise prices equal to the market price of the underlying Common Shares on the grant date and a term of 10 years. If available, Scotts Miracle-Gro typically uses treasury shares, or if not available, newly-issued Common Shares, to settle vested share-based awards. The Company classifies share-based compensation expense within cost of sales or selling, general and administrative expenses to correspond with the same line item as cash compensation paid to associates. Cash flows resulting from tax deductions in excess of the cumulative compensation cost recognized for share-based awards (excess tax benefits) are classified as operating cash inflows.

Cash and Cash Equivalents

Cash and cash equivalents are held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments. The Company considers all highly liquid financial instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash deposits in banks which from time to time exceed the amount of deposit insurance available. Management periodically assesses the financial condition of the Company’s banks and believes that the risk of any potential credit loss is minimal.

Accounts Receivable and Allowances

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Allowances for doubtful accounts reflect the Company’s estimate of amounts in its existing accounts receivable that may not be collected due to customer claims or customer inability or unwillingness to pay. The allowance is determined based on a combination of factors, including the Company’s ongoing risk assessment regarding the credit worthiness of its customers, historical collection experience and length of time the receivables are past due. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.

On October 27, 2023, the Company entered into the Master Receivables Purchase Agreement, under which the Company could sell up to $600.0 of available and eligible outstanding customer accounts receivable generated by sales to four specified customers. On September 1, 2024, the Company amended the Master Receivables Purchase Agreement to permit the Company to sell up to $750.0 of available and eligible outstanding customer accounts receivable generated by sales to five specified customers. The agreement is uncommitted and expires on September 1, 2025. The receivable sales are non-recourse to the Company, other than with respect to (i) repurchase obligations and indemnification obligations for any violations by the Company of its respective representations or obligations as seller or servicer and (ii) certain repurchase and payment obligations arising from any dilution of, or dispute with respect to, any purchased receivables that arise after the sale of such purchased receivables to the purchaser not contemplated in the applicable purchase price of such purchased receivable. The recourse obligations of the Company that may arise from time to time are supported by standby letters of credit of $75.0. Transactions under the Master Receivables Purchase Agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the Consolidated Balance Sheets at the time of the sales transaction. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the buyer are classified as financing cash flows in the Consolidated Statements of Cash Flows. The Company records the discount on sales in the “Other (income) expense, net” line in the Consolidated Statements of Operations. At September 30, 2024, net receivables of $186.6 were derecognized. During fiscal 2024, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $1,938.6 and the total discount recorded on sales was $24.6.

Inventories

Inventories are stated at the lower of cost or net realizable value and include the cost of raw materials, labor, manufacturing overhead and freight and inbound handling costs incurred to pre-position goods in the Company’s warehouse network. The Company makes provisions for obsolete or slow-moving inventories as necessary to properly reflect inventory at the lower of cost or net realizable value. Inventories are valued using the first in, first out method.

Investment in Unconsolidated Affiliates

Non-marketable equity investments in which the Company has the ability to exercise significant influence, but does not control, are accounted for using the equity method of accounting, with the Company’s proportionate share of the earnings and losses of these entities reflected in the Consolidated Statements of Operations. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, an impairment loss is recognized in earnings for the amount by which the carrying amount of the investment exceeds its estimated fair value.

Long-Lived Assets

Property, plant and equipment are stated at cost. Interest capitalized in property, plant and equipment amounted to $1.1, $2.1 and $2.2 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Expenditures for maintenance and repairs are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost of the asset and the related accumulated depreciation are removed from the accounts with the resulting gain or loss being reflected in income (loss) from operations.

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows:


Land improvements			10 – 25 years
Buildings			10 – 40 years
Machinery and equipment			3 – 15 years
Furniture and fixtures			6 – 10 years
Software			3 – 8 years

Intangible assets subject to amortization include technology, patents, customer relationships, non-compete agreements and certain trade names. These intangible assets are amortized over their estimated useful economic lives, which typically range from 3 to 25 years. The Company’s fixed assets and intangible assets subject to amortization are required to be tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group would be compared to the asset group carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

The Company had non-cash investing activities of $16.3, $32.1 and $33.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively, representing unpaid liabilities to acquire property, plant and equipment.

Internal Use Software

The Company capitalizes certain qualifying costs incurred in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest and payroll and payroll-related costs for associates during the application development stage. Internal and external costs incurred during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a straight-line basis over the software’s estimated useful life. Capitalized internal use software is included in the “Property, plant and equipment, net” line in the Consolidated Balance Sheets. Capitalized software as a service is included in the “Prepaid and other current assets” line in the Consolidated Balance Sheets and is amortized using the straight-line method over the term of the hosting arrangement which typically ranges from 3 to 8 years.

Goodwill and Indefinite-lived Intangible Assets

Goodwill and indefinite-lived intangible assets are not subject to amortization. These assets are reviewed for impairment by applying a fair-value based test on an annual basis as of the first day of the Company’s fiscal fourth quarter or more frequently if circumstances indicate impairment may have occurred. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include reporting unit specific operating results as well as new events and circumstances impacting the operations or cash flows of the reporting units. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of its reporting units to their respective fair values. A reporting unit is defined as an operating segment or one level below an operating segment. The Company determines the fair value of its reporting units using an income-based approach incorporating assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows that depend upon internally-developed forecasts based on annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainties inherent in the respective reporting units and in the internally-developed forecasts. To further substantiate fair value, the Company compares the aggregate fair value of the reporting units to the Company’s total market capitalization.

With respect to indefinite-lived intangible assets, the Company performs either a qualitative or quantitative evaluation for each asset. Factors considered in the qualitative test include asset specific operating results as well as new events and circumstances impacting the cash flows of the assets. For the quantitative test, the fair value of the Company’s indefinite-lived intangible assets is determined using an income-based approach utilizing discounted cash flows and incorporating assumptions the Company believes market participants would utilize. For trade names, fair value is determined using a relief-from-royalty methodology similar to that employed when the associated businesses were acquired but using updated estimates of sales, cash flow and profitability.

If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

Investments in Securities

Convertible debt investments are classified as “available for sale,” are reported at fair value and are presented in the “Other assets” line in the Consolidated Balance Sheets. If the fair value of an available for sale investment is less than its amortized cost basis at the balance sheet date, the impairment is either temporary or other-than-temporary. If a decline in fair value is considered to be temporary at the balance sheet date, unrealized gains and losses are included in accumulated other comprehensive loss (“AOCL”) in the Consolidated Balance Sheets. If management intends to sell the security or if it is more likely than not that the Company will have to sell the security, an other-than-temporary impairment is considered to have occurred and an amount equal to the difference between the investment’s amortized cost basis and its fair value at the balance sheet date will be charged to earnings. If a decline in fair value is considered to be other-than-temporary at the balance sheet date and management can assert that it does not intend to sell the security and it is not more likely than not that it will have to sell the security before recovering its amortized cost basis (net of allowance), an allowance for credit losses (impairment), including any write-off of accrued interest receivable, is charged to earnings. This impairment allowance is separated into two components: (i) the amount related to credit losses (recorded in earnings) and (ii) the amount related to all other factors (recorded in other comprehensive income / loss). Interest income is recorded on an accrual basis and is classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations.

Supplier Finance Program

The Company has an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance payment obligations of the Company with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance payment obligations of the Company prior to their scheduled due dates at a discounted price to the participating financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that the Company negotiates with its suppliers are consistent, regardless of whether a supplier participates in the program. The Company’s current payment terms with a majority of its suppliers generally range from 30 to 60 days, which the Company deems to be commercially reasonable. The Company’s outstanding payment obligations under its supplier finance program were $12.5 and $18.3 at September 30, 2024 and 2023, respectively, and are recorded within accounts payable in the Consolidated Balance Sheets. The associated payments were $245.5 and $185.3 for fiscal 2024 and fiscal 2023, respectively, and are classified as operating activities in the Consolidated Statements of Cash Flows.

Insurance and Self-Insurance

The Company maintains insurance for certain risks, including property damage, management liability, cargo liability, cyber threats, workers compensation and general liability losses, and is self-insured for employee-related health care benefits up to a specified level for individual claims. The Company accrues for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors and other relevant information. Costs are recognized in the period the claim is incurred, and accruals include an actuarially determined estimate of claims incurred but not yet reported.

Income Taxes

The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change.

The Company establishes a liability for tax return positions in which there is uncertainty as to whether or not the position will ultimately be sustained. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled. The Company recognizes interest expense and penalties related to these unrecognized tax benefits within income tax expense. GAAP provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.

Translation of Foreign Currencies

The functional currency for each Scotts Miracle-Gro subsidiary is generally its local currency. Assets and liabilities of these subsidiaries are translated at the exchange rate in effect at each fiscal year-end. Income and expense accounts are translated at the average rate of exchange prevailing during the year. Translation gains and losses arising from the use of differing exchange rates from period to period are included in AOCL within shareholders’ equity (deficit). Foreign exchange transaction gains and losses are included in the determination of net income and classified as “Other (income) expense, net” in the Consolidated Statements of Operations. The Company recognized foreign exchange transaction (gains) losses of $(0.4), $1.3 and $1.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Derivative Instruments

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. A variety of financial instruments, including forwards, futures and swap contracts, are used to manage these exposures. These financial instruments are recognized at fair value in the Consolidated Balance Sheets, and all changes in fair value are recognized in net income (loss) or shareholders’ equity (deficit) through AOCL. The Company’s objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow volatility associated with changes in the applicable rates and prices.

The Company has established policies and procedures that encompass risk-management philosophy and objectives, guidelines for derivative instrument usage, counterparty credit approval, and the monitoring and reporting of derivative activity. The Company does not enter into derivative instruments for the purpose of speculation.

The Company formally designates and documents instruments at inception that qualify for hedge accounting of underlying exposures in accordance with GAAP. The Company formally assesses, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the expected cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The Company designates certain commodity hedges as cash flow hedges of forecasted purchases of commodities and interest rate swap agreements as cash flow hedges of interest payments on variable rate borrowings. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCL. For commodity hedges, realized gains or losses remain as a component of AOCL until the related inventory is sold. Cash flows associated with commodity and interest rate swap hedges are classified as operating activities in the Consolidated Statements of Cash Flows.

Leases

The Company determines whether an arrangement contains a lease at inception by determining if the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration and other facts and circumstances. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date and initial direct costs incurred by the Company and exclude any lease incentives received from the lessor. Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. The lease term may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date based on the lease term. The Company considers its credit rating and the current economic environment in determining this collateralized rate. Variable lease payments are the portion of lease payments that are not fixed over the lease term. Variable lease payments are expensed as incurred and include certain non-lease components, such as maintenance and other services provided by the lessor, and other charges included in the lease, as applicable. The Company elected to exclude short-term leases, defined as leases with initial terms of 12 months or less, from its Consolidated Balance Sheets.

Statements of Cash Flows

Supplemental cash flow information was as follows:


	Year Ended September 30,
	2024		2023		2022

Interest paid	$	157.7	$	173.5	$	112.5


Income taxes paid (refunded), net	9.4		(18.2)		27.2

During fiscal 2024, the Company acquired an additional equity interest in Bonnie Plants, LLC for $21.4, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2023, the Company received proceeds of $37.0 related to the payoff of seller financing that the Company provided in connection with a fiscal 2017 divestiture, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2022, the Company made an additional investment in RIV Capital Inc. (“RIV Capital”) in the form of a $25.0 convertible note, which was classified as an investing activity in the Consolidated Statements of Cash Flows. The Company received (paid) cash of $2.6, $(12.4) and $29.3 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively, primarily associated with currency forward contracts, which was classified as an investing activity in the “Other investing, net” line in the Consolidated Statements of Cash Flows. Cash flow from operating activities in fiscal 2022 was favorably impacted by extended payment terms with vendors for payments originally due in the final weeks of fiscal 2022 that were paid in the first quarter of fiscal 2023.

The Company uses the “cumulative earnings” approach for determining cash flow presentation of distributions from unconsolidated affiliates. Distributions received are included in the Consolidated Statements of Cash Flows as operating activities, unless the cumulative distributions exceed the portion of the cumulative equity in the net earnings of the unconsolidated affiliate, in which case the excess distributions are deemed to be returns of the investment and are classified as investing activities in the Consolidated Statements of Cash Flows.

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-04, “Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires disclosure of the key terms of outstanding supplier finance programs and a roll-forward of the related obligations. ASU No. 2022-04 is effective for fiscal years beginning after December 15, 2022, except for the amendment on roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted the ASU as of October 1, 2023. The adoption relates to disclosures only and does not have any impact on the Company’s consolidated financial position, results of operations or cash flows.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker that are included within each reported measure of segment profit or loss, and also requires all annual disclosures currently required by Topic 280 to be included in interim periods. ASU No. 2023-07 is to be applied retrospectively for all periods presented in the financial statements and is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. ASU No. 2023-09 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In November 2024, the FASB issued ASU No. 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires disaggregated disclosures on an annual and interim basis, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of the statement of operations. ASU No. 2024-03 is to be applied prospectively, with the option to apply the standard retrospectively, effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

FAIR VALUE MEASUREMENTS - Additional Information (Details) shares in Millions, $ in Millions			12 Months Ended
	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	May 30, 2024	Apr. 22, 2022 board_member nominee director	Aug. 24, 2021 board_member	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
RIV Capital, Inc.
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of company nominees added to the board \| nominee							4
Number of members of Board of Directors that can be nominated							9	7
Debt Instrument, Ownership After Conversion, Common Shares \| shares	123.0
Percentage of ownership after debt conversion		47.00%
RIV Capital, Inc. \| The Hawthorne Colective
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of members of Board of Directors that can be nominated \| board_member							3
Operating expenses
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Convertible debt other-than-temporary impairments			$ 64.6	$ 101.3	$ 0.0
Senior Notes \| Senior Notes due 2031 – 4.000%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.00%	4.00%	4.00%	4.00%						4.00%
Senior Notes \| Senior Notes due 2032 – 4.375%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.375%	4.375%	4.375%	4.375%					4.375%
Senior Notes \| Senior Notes - 4.500%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.50%	4.50%	4.50%	4.50%							4.50%
Senior Notes \| Senior Notes due 2026 – 5.250%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	5.25%	5.25%	5.25%	5.25%								5.25%
Convertible Notes Payable \| RIV Capital, Inc.
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Conversion ratio on exchangeable shares						0.23
Convertible debt investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Reductions for securities intended to be sold			$ 99.4	$ 0.0
Cost basis of investment	$ 62.1	$ 225.8	62.1	225.8
Unrealized loss on investment			16.4	140.0
Allowance for credit loss	$ 1.9	$ 101.3	$ 1.9	$ 101.3	$ 0.0
Convertible debt investments \| Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt term (in years)			5 years
Convertible debt investments \| Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt term (in years)			2 years 10 months 24 days

EARNINGS PER COMMON SHARE - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Basic net loss per common share:
Weighted-average Common Shares outstanding during the period (in shares)	56.8	56.0	55.5
Basic net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)
Diluted net loss per common share:
Weighted-average Common Shares outstanding during the period (in shares)	56.8	56.0	55.5
Dilutive potential Common Shares (in shares)	0.0	0.0	0.0
Weighted-average number of Common Shares outstanding and dilutive potential Common Shares (in shares)	56.8	56.0	55.5
Diluted net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

ASSOCIATE MEDICAL BENEFITS - Retiree Medical Plan for Domestic Associates (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current liabilities	$ (73.0)	$ (76.7)
Postretirement Medical Benefits \| U.S. Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	13.3	15.7
Service cost	0.1	0.1
Interest cost	0.8	0.8
Plan participants’ contributions	0.3	0.4
Actuarial (gain) loss	1.5	(2.2)
Benefits paid	(2.2)	(1.5)
Projected benefit obligation (“PBO”) at end of year	13.8	13.3
Change in plan assets:
Fair value of plan assets at beginning of year	0.0	0.0
Employer contribution	1.9	1.1
Plan participants’ contributions	0.3	0.4
Gross benefits paid	(2.2)	(1.5)
Fair value of plan assets at end of year	0.0	0.0
Overfunded (underfunded) status at end of year	(13.8)	(13.3)
Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	(1.3)	(1.4)
Non-current liabilities	(12.5)	(11.9)
Total amount accrued	(13.8)	(13.3)
Amounts recognized in AOCL consist of:
Actuarial gain	(1.3)	(3.4)
Total amount recognized	(1.3)	(3.4)
Total change in other comprehensive income attributable to:
Gain (loss) during the period	(1.5)	2.2
Reclassification to net earnings	(0.6)	(0.2)
Total change in other comprehensive income	$ (2.1)	$ 2.0
Discount rate used in development of APBO	4.86%	5.98%

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Nature of Operations

Organization and Basis of Presentation

Use of Estimates

Advertising

Research and Development

Costs associated with research and development are generally charged to expense as incurred.

Environmental Costs

Earnings per Common Share

Share-Based Compensation Awards

Cash and Cash Equivalents

Accounts Receivable and Allowances

Inventories

Investment in Unconsolidated Affiliates

Long-lived Assets

Long-Lived Assets

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows:


Land improvements			10 – 25 years
Buildings			10 – 40 years
Machinery and equipment			3 – 15 years
Furniture and fixtures			6 – 10 years
Software			3 – 8 years

Internal Use Software

Goodwill and Indefinite-lived Intangible Assets

Investments in Securities

Supplier Finance Program

Insurance and Self-Insurance

Income Taxes

Translation of Foreign Currencies

Derivative Instruments

Leases

Recently Adopted and Recently Issued Accounting Pronouncements

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Revenue Recognition

Nature of Goods and Services

The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. Refer to “NOTE 20. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 6. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements.

Identification and Satisfaction of Performance Obligations

The Company recognizes product sales at a point in time when it transfers control of products to customers and has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction and, therefore, primarily records revenue on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer.

Under the terms of the Third Restated Agreement, pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Third Restated Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income.

Transactional Price and Promotional Allowances

Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto agreements is recognized over the program year as the services are performed based upon the commission income formula in the agreements.

The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.

IMPAIRMENT, RESTRUCTURING AND OTHER

12 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

IMPAIRMENT, RESTRUCTURING AND OTHER

Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:


	Year Ended September 30,
	2024		2023		2022

Cost of sales—impairment, restructuring and other:
Restructuring and other charges, net	$	72.9	$	148.5	$	143.6
Property, plant and equipment impairments	5.3		11.4		16.6
Right-of-use asset impairments	5.3		25.8		—

Operating expenses—impairment, restructuring and other:
Convertible debt other-than-temporary impairments	64.6		101.3		—
Goodwill and intangible asset impairments	2.5		127.9		668.3
Restructuring and other charges (recoveries), net	(4.3)		51.2		40.9
Gains on sale of property, plant and equipment	—		—		(16.2)


Total impairment, restructuring and other charges	$	146.3	$	466.1	$	853.2

The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:


	Year Ended September 30,
	2024		2023		2022

Amounts accrued at beginning of year	$	40.5	$	31.5	$	1.9
Restructuring charges	11.8		55.6		47.1

Payments	(33.4)		(46.6)		(17.5)
Amounts accrued at end of year	$	18.9	$	40.5	$	31.5

As of September 30, 2024, restructuring accruals include $5.7 that is classified as long-term.

During fiscal 2024 and fiscal 2023, the Company recorded non-cash, pre-tax other-than-temporary impairment charges related to its convertible debt investments of $64.6 and $101.3, respectively, in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. Refer to “NOTE 16. FAIR VALUE MEASUREMENTS” for more information regarding convertible debt investments.

During fiscal 2024, the Company recorded a gain of $12.1 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with a payment received in resolution of a dispute with the former ownership group of a business that was acquired in fiscal 2022.

During fiscal 2022, the Company began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring initiative, the Company reduced the size of its supply chain network, reduced staffing levels and implemented other cost-reduction initiatives. The Company also accelerated the reduction of certain Hawthorne inventory, primarily lighting, growing environments and hardware products, to reduce on hand inventory to align with the reduced network capacity. During fiscal 2024, the Company incurred costs of $89.4 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets, intangible assets, property, plant and equipment and software. The Company incurred costs of $11.3 in its U.S. Consumer segment and $71.8 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. The Company incurred costs of $1.5 in its U.S. Consumer segment, $1.0 in its Hawthorne segment, $1.1 in its Other segment and $2.4 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2024. During fiscal 2023, the Company incurred costs of $229.0 associated with this restructuring initiative primarily related to inventory write-down charges, employee termination benefits, facility closure costs and impairment of right-of-use assets and property, plant and equipment. The Company incurred costs of $16.3 in its U.S. Consumer segment and $168.5 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2023. The Company incurred costs of $7.7 in its U.S. Consumer segment, $20.7 in its Hawthorne segment, $0.8 in its Other segment and $14.9 at Corporate in the “Impairment, restructuring and other”

line in the Consolidated Statements of Operations during fiscal 2023. During fiscal 2022, the Company incurred costs of $65.2 associated with this restructuring initiative primarily related to employee termination benefits and impairment of property, plant and equipment. The Company incurred costs of $9.7 in its U.S. Consumer segment and $27.1 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. The Company incurred costs of $11.9 in its U.S. Consumer segment, $8.1 in its Hawthorne segment, $0.7 in its Other segment and $7.7 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. Costs incurred since the inception of this restructuring initiative through September 30, 2024 were $58.3 for the U.S. Consumer segment, $297.2 for the Hawthorne segment, $2.9 for the Other segment and $25.1 at Corporate.

During fiscal 2023, the Company recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $127.9 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $117.7 of finite-lived intangible asset impairment charges associated with the Hawthorne segment and $10.3 of goodwill impairment charges associated with the Other segment.

During fiscal 2022, the Company recorded non-cash, pre-tax goodwill and intangible asset impairment charges of $632.4 as a result of interim impairment testing of its Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $522.4 of goodwill impairment charges and $110.0 of finite-lived intangible asset impairment charges.

During fiscal 2022, the Company incurred inventory write-down charges of $120.9 in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations and finite-lived intangible asset impairment charges of $35.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with its decision to discontinue and exit the market for certain Hawthorne lighting products and brands.

During fiscal 2022, the Company recorded gains of $16.2 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with the sale of property, plant and equipment.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Schedule of Estimated Useful Economic Lives of Property, Plant and Equipment

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows:


Land improvements			10 – 25 years
Buildings			10 – 40 years
Machinery and equipment			3 – 15 years
Furniture and fixtures			6 – 10 years
Software			3 – 8 years

Schedule of Supplemental Cash Flow Information

Supplemental cash flow information was as follows:


	Year Ended September 30,
	2024		2023		2022

Interest paid	$	157.7	$	173.5	$	112.5


Income taxes paid (refunded), net	9.4		(18.2)		27.2

IMPAIRMENT, RESTRUCTURING AND OTHER - Schedule of Impairment, Restructuring, and Other Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	$ 62.8	$ 280.5	$ 693.1
Total impairment, restructuring and other charges	146.3	466.1	853.2
Restructuring Reserve
Amounts accrued at beginning of year	40.5	31.5	1.9
Restructuring charges	11.8	55.6	47.1
Payments	(33.4)	(46.6)	(17.5)
Amounts accrued at end of year	18.9	40.5	31.5
Operating expenses
Restructuring Cost and Reserve [Line Items]
Goodwill and intangible asset impairments	2.5	127.9	668.3
Convertible debt other-than-temporary impairments	64.6	101.3	0.0
Gains on sale of property, plant and equipment	0.0	0.0	(16.2)
Restructuring and other charges (recoveries), net \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	72.9	148.5	143.6
Restructuring and other charges (recoveries), net \| Operating expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	(4.3)	51.2	40.9
Property, plant and equipment impairments \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	5.3	11.4	16.6
Right-of-use Asset Impairment \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges, net	$ 5.3	$ 25.8	$ 0.0

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)

12 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Rollforward of Carrying Amount of Goodwill by Reportable Segment

The following table displays a rollforward of the carrying amount of goodwill by reportable segment:


	U.S. Consumer		Hawthorne		Other		Total
Goodwill	$	245.7	$	617.0	$	10.1	$	872.8
Accumulated impairment losses	(1.8)		(617.0)		—		(618.8)
Balance at September 30, 2022	243.9		—		10.1		254.0

Foreign currency translation	—		—		0.2		0.2

Impairment	—		—		(10.3)		(10.3)

Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2023	243.9		—		—		243.9






Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2024	$	243.9	$	—	$	—	$	243.9

Schedule of Finite-lived Intangible Assets

The following table presents intangible assets, net of accumulated amortization and impairment charges:


	September 30, 2024						September 30, 2023
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount

Finite-lived intangible assets:
Trade names	$	325.8	$	(272.8)	$	53.0	$	322.4	$	(260.7)	$	61.7
Customer relationships	253.1		(223.9)		29.2		251.5		(216.1)		35.4
Technology	50.2		(45.5)		4.7		50.1		(44.5)		5.6
Other	35.0		(27.0)		8.0		34.9		(24.8)		10.1
Total finite-lived intangible assets, net					94.9						112.8
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7

Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	418.8					$	436.7

Schedule of Indefinite-lived Intangible Assets

The following table presents intangible assets, net of accumulated amortization and impairment charges:


	September 30, 2024						September 30, 2023
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount

Finite-lived intangible assets:
Trade names	$	325.8	$	(272.8)	$	53.0	$	322.4	$	(260.7)	$	61.7
Customer relationships	253.1		(223.9)		29.2		251.5		(216.1)		35.4
Technology	50.2		(45.5)		4.7		50.1		(44.5)		5.6
Other	35.0		(27.0)		8.0		34.9		(24.8)		10.1
Total finite-lived intangible assets, net					94.9						112.8
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7

Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	418.8					$	436.7

Schedule of Future Estimates of Amortization Expense

Amortization expense is estimated to be as follows for the years ending September 30:


2025	$	12.6
2026	11.5
2027	10.7
2028	9.1
2029	6.9

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

+ Details

DEBT - Interest Rate Swap Agreements (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Interest Rate Swap, Instrument 1
Derivative [Line Items]
Notional amount	$ 150.0
Fixed rate (percentage)	3.37%
Interest Rate Swap, Instrument 2
Derivative [Line Items]
Notional amount	$ 50.0
Fixed rate (percentage)	3.34%
Interest Rate Swap, Instrument 3
Derivative [Line Items]
Notional amount	$ 100.0
Fixed rate (percentage)	4.74%
Interest Rate Swap, Instrument 4
Derivative [Line Items]
Notional amount	$ 150.0
Fixed rate (percentage)	4.25%
Designated as Hedging Instruments \| Interest rate swap agreements
Derivative [Line Items]
Cash payment from terminated interest rate swap agreement	$ 11.0
Notional amount	$ 450.0	$ 600.0

SEGMENT INFORMATION - Segment Financial Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
Intangible asset amortization	(15.7)	(25.2)	(37.1)
Impairment, restructuring and other	(62.8)	(280.5)	(693.1)
Equity in loss of unconsolidated affiliates	(68.1)	(101.1)	(12.9)
Interest expense	(158.8)	(178.1)	(118.1)
Other non-operating income (expense), net	(5.5)	0.3	6.9
Depreciation and amortization	80.6	92.5	105.2
Capital expenditures	84.0	92.8	113.5
Assets	2,871.9	3,413.7
Corporate
Segment Reporting Information [Line Items]
Depreciation and amortization	1.8	2.9	7.6
Assets	272.6	346.1
U.S. Consumer
Segment Reporting Information [Line Items]
Net sales	3,013.7	2,843.7	2,928.8
Capital expenditures	81.5	79.6	97.4
U.S. Consumer \| Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	56.2	58.2	55.8
Assets	2,022.7	2,296.2
Hawthorne
Segment Reporting Information [Line Items]
Net sales	294.7	467.3	716.2
Capital expenditures	0.0	8.5	12.4
Hawthorne \| Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	16.7	25.8	34.8
Assets	387.3	581.6
Other
Segment Reporting Information [Line Items]
Net sales	244.3	240.3	279.1
Capital expenditures	2.5	4.7	3.7
Other \| Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	5.9	5.6	7.0
Assets	189.3	189.8
Continuing Operations
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(23.6)	(453.3)	(558.1)
Intangible asset amortization	(15.7)	(25.2)	(37.1)
Impairment, restructuring and other	(146.3)	(466.0)	(852.2)
Equity in loss of unconsolidated affiliates	(68.1)	(101.1)	(12.9)
Interest expense	(158.8)	(178.1)	(118.1)
Other non-operating income (expense), net	(5.5)	0.3	6.9
Continuing Operations \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	488.5	418.4	567.7
Continuing Operations \| Corporate
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(117.7)	(101.6)	(112.4)
Continuing Operations \| U.S. Consumer \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	498.0	454.1	568.6
Continuing Operations \| Hawthorne \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(14.2)	(48.1)	(21.1)
Continuing Operations \| Other \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	$ 4.7	$ 12.4	$ 20.2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Accounting Policies [Abstract]
Interest paid	$ 157.7	$ 173.5	$ 112.5
Income taxes paid (refunded), net	$ 9.4	$ (18.2)	$ 27.2

REVENUE RECOGNITION	12 Months Ended
REVENUE RECOGNITION	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
REVENUE RECOGNITION	REVENUE RECOGNITION Nature of Goods and Services The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. Refer to “NOTE 20. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 6. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements. Identification and Satisfaction of Performance Obligations The Company recognizes product sales at a point in time when it transfers control of products to customers and has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction and, therefore, primarily records revenue on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer. Under the terms of the Third Restated Agreement, pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Third Restated Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income. Transactional Price and Promotional Allowances Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto agreements is recognized over the program year as the services are performed based upon the commission income formula in the agreements. The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

+ Details

INCOME TAXES

12 Months Ended

Sep. 30, 2024

Income Tax Disclosure [Abstract]

INCOME TAXES

The provision (benefit) for income taxes consisted of the following:


	Year Ended September 30,
	2024		2023		2022

Current:
Federal	$	2.4	$	3.7	$	22.8
State	2.5		0.6		9.3
Foreign	(5.3)		1.6		8.7
Total current	(0.4)		5.9		40.8
Deferred:
Federal	11.6		(62.1)		(125.5)
State	(3.8)		(5.2)		(23.3)
Foreign	3.9		(11.8)		(12.6)
Total deferred	11.7		(79.1)		(161.4)
Income tax expense (benefit)	$	11.3	$	(73.2)	$	(120.6)

The domestic and foreign components of loss before income taxes were as follows:


	Year Ended September 30,
	2024		2023		2022

Domestic	$	(10.8)	$	(376.2)	$	(427.3)
Foreign	(12.8)		(77.1)		(130.8)
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)

A reconciliation of the federal corporate income tax rate and the effective tax rate on loss before income taxes is summarized below:


	Year Ended September 30,
	2024		2023		2022
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.0)		0.2		(1.6)
State taxes, net of federal benefit	8.0		3.2		2.6
Effect of other permanent differences	(32.8)		(0.8)		2.8
Research and Experimentation and other federal tax credits	2.9		0.2		0.2
Effect of tax contingencies	3.7		0.1		(1.8)
Change in valuation allowances	(57.4)		(8.7)		(0.9)
Other	8.7		1.0		(0.7)
Effective income tax rate	(47.9)	%	16.2	%	21.6	%

Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the deferred income tax assets and liabilities were as follows:


	September 30,
	2024		2023

DEFERRED TAX ASSETS
Lease liabilities	$	67.6	$	70.0
Intangible assets	62.2		79.2
Net operating loss carryovers	56.4		67.3
Interest limitation carryforward	55.9		35.9
Convertible debt investments	43.6		33.4
Accrued liabilities	43.2		48.7
Outside basis difference in equity investments	23.1		10.4
Inventories	16.1		26.1
Foreign tax credit carryovers	15.2		16.3

Other	22.4		23.8
Gross deferred tax assets	405.7		411.1
Valuation allowance	(96.5)		(87.7)
Total deferred tax assets	309.2		323.4
DEFERRED TAX LIABILITIES
Lease right-of-use assets	(62.0)		(62.1)
Property, plant and equipment	(58.5)		(62.7)


Other	(4.4)		(9.9)
Total deferred tax liabilities	(124.9)		(134.7)
Net deferred tax asset	$	184.3	$	188.7

At September 30, 2024 and 2023, after netting by taxing jurisdiction, net deferred tax assets of $191.3 and $189.8, respectively, were recorded in the “Other assets” line in the Consolidated Balance Sheets, and net deferred tax liabilities of $7.0 and $1.1, respectively, were recorded in the “Other liabilities” line in the Consolidated Balance Sheets.

GAAP requires that a valuation allowance be recorded against a deferred tax asset if it is more likely than not that the tax benefit associated with the asset will not be realized in the future. As shown in the table above, valuation allowances were recorded against $96.5 and $87.7 of deferred tax assets as of September 30, 2024 and 2023, respectively. Most of these valuation allowances relate to losses on convertible debt investments, credits, and net operating losses (“NOLs”), as explained further below.

Deferred tax assets related to unrealized losses on convertible debt investments were $43.6 and $33.4 at September 30, 2024 and 2023, respectively. A full valuation allowance was recorded against these losses at September 30, 2024 and 2023 as the Company does not expect to utilize them prior to their expiration.

Deferred tax assets related to foreign tax credits were $15.2 and $16.3 at September 30, 2024 and 2023, respectively. A full valuation allowance was recorded against these credits as of September 30, 2024 and 2023 as the Company does not expect to utilize them prior to their expiration. Tax benefits associated with state tax credits will also expire if not utilized and amounted to $1.0 and $1.4 at September 30, 2024 and 2023, respectively. A valuation allowance in the amount of $0.8 and $1.3 was recorded at September 30, 2024 and 2023, respectively, related to state credits the Company does not expect to utilize.

Deferred tax assets related to certain federal NOLs subject to limitation under IRC §382 from current and prior ownership changes were $9.9 and $10.5 at September 30, 2024 and 2023, respectively. These NOLs will be subject to expiration gradually from fiscal year end 2024 through fiscal year end 2032. The Company determined that a portion of these deferred tax assets will expire unutilized due to the closing of statutes of limitation and has recorded a valuation allowance of $9.7 and $10.2 at September 30, 2024 and 2023, respectively. The Company had deferred tax assets related to federal NOLs not subject to limitation of $20.6 at September 30, 2024, which can be utilized to reduce future years’ tax liabilities.

Deferred tax assets related to foreign NOLs of certain controlled foreign corporations were $6.8 and $8.3 as of September 30, 2024 and 2023, respectively. Due to a history of losses, a valuation allowance of $4.6 and $6.4 has been recorded against these deferred tax assets as of September 30, 2024 and 2023, respectively. A valuation allowance has also been recorded against deferred tax assets related to other foreign items of $13.0 and $11.0 at September 30, 2024 and 2023, respectively.

Deferred tax assets related to state NOLs were $19.1 and $15.2 as of September 30, 2024 and 2023, respectively, with carryforward periods ranging from 5 to unlimited years. Any losses not utilized within a specific state’s carryforward period will expire. A valuation allowance was recorded against $7.0 and $6.9 of these deferred tax assets as of September 30, 2024 and 2023, respectively, for state NOLs that the Company does not expect to realize within their respective carryforward periods. A valuation allowance has also been recorded against deferred tax assets related to other state items of $2.6 and $2.2 at September 30, 2024 and 2023, respectively.

As of September 30, 2024, the Company maintains its assertions of indefinite reinvestment of the earnings of all material foreign subsidiaries.

The Company had $25.7, $34.6 and $35.8 of gross unrecognized tax benefits related to uncertain tax positions at September 30, 2024, 2023 and 2022, respectively. Included in the September 30, 2024, 2023 and 2022 balances were $23.1, $31.1 and $31.5, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.

A reconciliation of the unrecognized tax benefits is as follows:


	Year Ended September 30,
	2024		2023		2022

Balance at beginning of year	$	34.6	$	35.8	$	24.1
Additions for tax positions of the current year	0.2		0.2		11.3
Additions for tax positions of prior years	0.1		3.8		2.2
Reductions for tax positions of prior years	(3.7)		(0.2)		(2.5)
Settlements with tax authorities	(0.7)		(0.1)		1.3
Expiration of statutes of limitation	(4.8)		(4.9)		(0.6)
Balance at end of year	$	25.7	$	34.6	$	35.8

The Company continues to recognize accrued interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes. As of September 30, 2024, 2023 and 2022, the Company had $5.8, $3.9 and $3.2, respectively, accrued for the payment of interest that, if recognized, would impact the effective tax rate. The Company had $1.1, $1.3 and $1.6 accrued for the payment of penalties as of September 30, 2024, 2023 and 2022, respectively.

Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2021. There are currently no ongoing audits with respect to the U.S. federal jurisdiction. With respect to the foreign jurisdictions, a Canadian audit covering fiscal years 2020 through 2021 is in process. The Company is currently under examination by certain U.S. state and local tax authorities covering various periods from fiscal years 2018 through 2023. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

The Company currently anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although the outcomes of such examinations and the timing of any payments required upon the conclusion of such examinations are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

EQUITY - Schedule of Authorized and Issued Shares (Details) - $ / shares	Sep. 30, 2024	Sep. 30, 2023
Preferred shares, no par value:
Authorized (in shares)	200,000	200,000
Issued (in shares)	0.0	0.0
Common shares, no par value, $0.01 stated value per share:
Authorized (in shares)	100,000,000.0	100,000,000.0
Issued (in shares)	68,100,000	68,100,000
Common shares, stated value per share (USD per share)	$ 0.01	$ 0.01

EQUITY - Summary of Certain Information Pertaining to Stock Option Awards Outstanding and Exercisable (Details) - Options - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]
No. of Options (in shares)	2,377,672	1,191,183
Wtd. Avg. Remaining Life (in years)	7 years 6 months	6 years 7 months 6 days
WTD. Avg. Exercise Price (USD per share)	$ 65.03	$ 76.64
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
No. of Options (in shares)	493,832
WTD. Avg. Exercise Price (USD per share)	$ 108.97

COMMITMENTS (Tables)

12 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Unconditional Purchase Obligations That Have Not Been Recognized

At September 30, 2024, the Company had the following unconditional purchase obligations by purchase date that have not been recognized in the Consolidated Balance Sheet:


2025	$	310.9
2026	193.5
2027	79.2
2028	39.3
2029	24.6
Thereafter	33.7
	$	681.2

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Other comprehensive income (loss):
Net foreign currency translation adjustment	0.6	7.0	(27.2)
Net unrealized gain (loss) on derivative instruments, net of tax	(7.9)	4.2	29.9
Reclassification of net unrealized gain on derivative instruments to net loss, net of tax	(7.3)	(17.4)	(6.8)
Net unrealized loss on securities, net of tax	(40.4)	(34.9)	(77.4)
Reclassification of net unrealized loss on securities to net loss, net of tax	64.6	76.0	0.0
Net unrealized loss in pension and other post-retirement benefits, net of tax	(2.1)	(1.8)	(5.4)
Pension and other post-retirement benefit adjustments, net of tax	(2.0)	(1.3)	8.7
Total other comprehensive income (loss)	5.5	31.8	(78.2)
Comprehensive loss	$ (29.4)	$ (348.3)	$ (515.7)

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared (USD per share)	$ 2.64	$ 2.64	$ 2.64

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Sep. 30, 2024	Nov. 18, 2024	Mar. 28, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Sep. 30, 2024
Current Fiscal Year End Date	--09-30
Document Transition Report	false
Entity File Number	001-11593
Entity Registrant Name	Scotts Miracle-Gro Co
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	31-1414921
Entity Address, Address Line One	14111 Scottslawn Road,
Entity Address, City or Town	Marysville,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43041
City Area Code	937
Local Phone Number	644-0011
Title of 12(b) Security	Common Shares, $0.01 stated value
Trading Symbol	SMG
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 3,178,556,405
Entity Common Stock, Shares Outstanding		57,406,064
Documents Incorporated by Reference	Portions of the definitive Proxy Statement for the registrant’s 2025 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended September 30, 2024.
Entity Central Index Key	0000825542
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

RETIREMENT PLANS - Plan Asset Allocations and Expected Future Benefit Payments (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2023
International Plan
Plan asset allocations:
Expected company contributions in fiscal 2025		$ 0.9
Expected future benefit payments:
2025		7.3
2026		7.4
2027		7.4
2028		7.6
2029		7.8
2030 – 2034		$ 40.5
International Plan \| Equity securities
Plan asset allocations:
Plan asset allocations		0.00%	0.00%
International Plan \| Equity securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
International Plan \| Debt securities
Plan asset allocations:
Plan asset allocations		0.00%	5.00%
International Plan \| Debt securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
International Plan \| Real estate securities
Plan asset allocations:
Plan asset allocations		0.00%	0.00%
International Plan \| Real estate securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
International Plan \| Cash and cash equivalents
Plan asset allocations:
Plan asset allocations		15.00%	11.00%
International Plan \| Cash and cash equivalents \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	15.00%
International Plan \| Insurance contracts
Plan asset allocations:
Plan asset allocations		85.00%	84.00%
International Plan \| Insurance contracts \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	85.00%
U.S. Plan
Plan asset allocations:
Expected company contributions in fiscal 2025		$ 2.7
Expected future benefit payments:
2025		7.5
2026		7.0
2027		6.9
2028		6.7
2029		6.5
2030 – 2034		$ 28.4
U.S. Plan \| Equity securities
Plan asset allocations:
Plan asset allocations		19.00%	18.00%
U.S. Plan \| Equity securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	19.00%
U.S. Plan \| Debt securities
Plan asset allocations:
Plan asset allocations		74.00%	75.00%
U.S. Plan \| Debt securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	76.00%
U.S. Plan \| Real estate securities
Plan asset allocations:
Plan asset allocations		2.00%	3.00%
U.S. Plan \| Real estate securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	3.00%
U.S. Plan \| Cash and cash equivalents
Plan asset allocations:
Plan asset allocations		5.00%	4.00%
U.S. Plan \| Cash and cash equivalents \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	2.00%
U.S. Plan \| Insurance contracts
Plan asset allocations:
Plan asset allocations		0.00%	0.00%
U.S. Plan \| Insurance contracts \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%

INVESTMENT IN UNCONSOLIDATED AFFILIATES	12 Months Ended
INVESTMENT IN UNCONSOLIDATED AFFILIATES	Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENT IN UNCONSOLIDATED AFFILIATES	INVESTMENT IN UNCONSOLIDATED AFFILIATES The Company holds a 50% equity interest in Bonnie Plants, LLC, a joint venture with AFC focused on planting, growing, developing, distributing, marketing and selling live plants. During the three months ended December 31, 2022, the Company and AFC amended the joint venture agreement to allow AFC to make an additional equity contribution to Bonnie Plants, LLC, and, as a result of this contribution by AFC, the Company’s equity interest in Bonnie Plants, LLC was reduced to 45%. On November 7, 2023, the Company purchased an additional 5% equity interest in Bonnie Plants, LLC from AFC for $21.4, which restored its total equity interest back to 50%. The Company’s interest is accounted for using the equity method of accounting, with the Company’s proportionate share of Bonnie Plants, LLC earnings reflected in the Consolidated Statements of Operations. The Company recorded equity in loss of unconsolidated affiliates associated with Bonnie Plants, LLC of $68.1, $101.1 and $12.9 during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The Company recorded pre-tax impairment charges associated with its investment in Bonnie Plants, LLC of $61.9 and $94.7 in the “Equity in loss of unconsolidated affiliates” line in the Consolidated Statements of Operations during fiscal 2024 and fiscal 2023, respectively. The impairment charges were driven by revisions to the Company’s internal forecasts for Bonnie Plants, LLC in response to decreased sales volume and inflationary cost pressures. The estimated fair value of Bonnie Plants, LLC was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to the operating performance of the investment. The fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements. As a result of the impairment charges recorded by the Company during fiscal 2024 and fiscal 2023, the carrying value of the Company’s equity method investment is lower than its interest in Bonnie Plants, LLC’s underlying net assets as of September 30, 2024. Of this basis difference, the majority relates to goodwill and indefinite-lived intangible assets recorded by Bonnie Plants, LLC, which are not amortized. The remaining amount relates to long-lived assets, including finite-lived intangible assets, and will be amortized over the remaining useful life of the long-lived assets.

RETIREMENT PLANS - Components of Net Periodic Benefit Cost and Weighted Average Assumptions (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
International Plan
Components of net periodic benefit cost (income):
Interest cost	$ 5.9	$ 6.2	$ 3.0
Expected return on plan assets	(5.7)	(5.5)	(5.1)
Net amortization	2.3	2.0	1.3
Net periodic benefit cost (income)	$ 2.5	$ 2.7	$ (0.8)
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	5.38%	5.29%	1.64%
Expected return on plan assets	4.42%	3.91%	2.37%
U.S. Plan
Components of net periodic benefit cost (income):
Interest cost	$ 3.7	$ 3.6	$ 1.7
Expected return on plan assets	(2.2)	(2.5)	(2.8)
Net amortization	1.7	1.8	1.7
Net periodic benefit cost (income)	$ 3.2	$ 2.9	$ 0.6
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	5.46%	4.87%	1.74%
Expected return on plan assets	4.25%	4.50%	3.50%

LEASES - (Maturities of Lease Liabilities by Fiscal Year Schedule) (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2025	$ 89.8
2026	73.5
2027	49.2
2028	38.8
2029	27.1
Thereafter	62.5
Total lease payments	340.9
Less: Imputed interest	(49.8)
Total lease liabilities	291.1	$ 296.5
Finance Lease, Liability, Payment, Due [Abstract]
2025	3.4
2026	3.0
2027	2.6
2028	2.2
2029	1.7
Thereafter	8.6
Total lease payments	21.5
Less: Imputed interest	(3.7)
Total lease liabilities	$ 17.8	$ 16.9

EQUITY - Performance-Based Awards, Additional Information (Details) - Performance-Based Units - USD ($) $ / shares in Units, $ in Millions	2 Months Ended	12 Months Ended
	Nov. 22, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Weighted average grant date fair value (in USD per share)		$ 74.57	$ 66.00	$ 132.74
Compensation costs net yet recognized		$ 7.6
Total fair value of share-based payment awards vested		$ 10.6	$ 17.4	$ 182.5
Expected weighted average period for unrecognized compensation cost (in years)		2 years 1 month 6 days
Award vesting period (in years)		3 years
Share-based compensation awards granted, other than options (in shares)		240,677
Liability awards accrued		$ 20.2
Cost not yet recognized		$ 0.0
Subsequent Event
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Share-based compensation awards granted, other than options (in shares)	300,000

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 71.6	$ 31.9
Accounts receivable, less allowances of $9.6 in 2024 and $15.1 in 2023	176.8	304.2
Inventories	587.5	880.3
Prepaid and other current assets	144.5	181.4
Total current assets	980.4	1,397.8
Investment in unconsolidated affiliates	45.2	91.9
Property, plant and equipment, net	609.5	610.3
Goodwill	243.9	243.9
Intangible assets, net	418.8	436.7
Other assets	574.1	633.1
Total assets	2,871.9	3,413.7
Current liabilities:
Current portion of debt	52.6	52.3
Accounts payable	254.7	271.2
Other current liabilities	443.0	450.2
Total current liabilities	750.3	773.7
Long-term debt	2,174.2	2,557.4
Other liabilities	338.0	349.9
Total liabilities	3,262.5	3,681.0
Commitments and contingencies (Notes 17, 18 and 19)
Equity (deficit):
Common shares and capital in excess of $0.01 stated value per share; shares outstanding of 57.1 and 56.5, respectively	362.0	353.1
Retained earnings	303.8	490.9
Treasury shares, at cost; 11.0 and 11.6 shares, respectively	(949.1)	(998.5)
Accumulated other comprehensive loss	(107.3)	(112.8)
Total equity (deficit)	(390.6)	(267.3)
Total liabilities and equity (deficit)	$ 2,871.9	$ 3,413.7

ASSOCIATE MEDICAL BENEFITS - Additional Information (Details) $ in Millions	12 Months Ended
	Sep. 30, 2024 USD ($) Year	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Self-insurance per occurrence	$ 1.0
Benefits cost recognized	$ 42.5	$ 40.1	$ 46.6
Health care cost trend rate (percent)	6.50%
Ultimate trend rate (percent)	4.50%
U.S. Plan \| Postretirement Medical Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Minimum retirement age (in years) \| Year	55
Number of years of service (in years)	10 years
Net periodic benefit (income)	$ 0.3	$ 0.7	$ (0.2)

RETIREMENT PLANS - Additional Information (Details) $ in Millions	12 Months Ended
	Sep. 30, 2024 USD ($) plan	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Compensation charges \| $	$ 23.7	$ 24.1	$ 28.3
401(K) \| Company matches 200% of associates’ initial 3% contribution
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer match of employee contribution (percent)	200.00%
Employee contribution of gross pay (percent)	3.00%
401(K) \| Company matches 50% of associates' contribution up to 6%
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer match of employee contribution (percent)	50.00%
Employee contribution of gross pay (percent)	6.00%
Deferred Profit Sharing
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employee contribution of gross pay (percent)	4.00%
Defined Benefit Pension Plan \| International Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of frozen defined benefit pension plans associated with former international businesses \| plan	3
Premium payment \| $	$ 76.3		$ 67.7
Defined Benefit Pension Plan \| U.S. Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of defined benefit plans for certain U.S. associates \| plan	2

EARNINGS PER COMMON SHARE

12 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

EARNINGS PER COMMON SHARE

The following table presents information necessary to calculate basic and diluted net loss per Common Share for the periods indicated:


	Year Ended September 30,
	2024		2023		2022





Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Basic net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5


Basic net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Diluted net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Dilutive potential common shares	—		—		—
Weighted-average number of common shares outstanding and dilutive potential common shares	56.8		56.0		55.5


Diluted net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)

Antidilutive stock options outstanding	0.4		0.4		0.2

Diluted average common shares used in the diluted loss per common share calculation for fiscal 2024, fiscal 2023 and fiscal 2022 were 56.8 million, 56.0 million and 55.5 million, respectively, which excluded potential common shares of 0.9 million, 0.4 million and 0.6 million, respectively, because the effect of their inclusion would be anti-dilutive as the Company incurred a net loss for fiscal 2024, 2023 and 2022.

SEGMENT INFORMATION - Concentrations of Credit Risk (Details) - Customer Concentration Risk	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Net Sales \| Home Depot
Revenue, Major Customer [Line Items]
Concentration risk (percent)	30.00%	29.00%	28.00%
Net Sales \| Lowe's
Revenue, Major Customer [Line Items]
Concentration risk (percent)	18.00%	18.00%	15.00%
Net Accounts Receivable \| Two Largest Customers
Revenue, Major Customer [Line Items]
Concentration risk (percent)	18.00%	41.00%

SUBSEQUENT EVENT	12 Months Ended
SUBSEQUENT EVENT	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENT	SUBSEQUENT EVENTOn November 26, 2024, the Company announced that Matthew Garth, Executive Vice President, Chief Financial Officer & Chief Administrative Officer, will be departing the Company effective December 31, 2024 (the “Termination Date”). In connection with Mr. Garth’s departure on the Termination Date, the Company entered into a Separation Agreement and Release of All Claims (the “Separation Agreement”) with Mr. Garth on November 25, 2024. The Separation Agreement addresses the payments and benefits to which Mr. Garth is entitled in connection with his departure. The Company will pay or make the following benefits available to Mr. Garth in connection with his departure: (a) pay equal to 24 months of salary, at Mr. Garth’s regular monthly base pay, payable in accordance with the Company’s standard payroll procedures; (b) in lieu of outplacement services, a lump sum payment of $0.03; (c) for a period of 24 months, a benefits offset payment in an amount equal to the excess of the COBRA premium charged by the Company to terminated employees over the premium Mr. Garth paid as an active employee; and (d) an amount equal to two times Mr. Garth’s target bonus opportunity for the fiscal year ending September 30, 2025, 50% of which is payable on the first scheduled pay date following the first anniversary of Mr. Garth’s Termination Date and 50% of which is payable on the first scheduled pay date following the second anniversary of Mr. Garth’s Termination Date, subject to Mr. Garth’s continued compliance as of the payment date with all of his post-employment obligations to the Company. Additionally, Mr. Garth will fully and partially vest in certain equity-based awards upon his departure from the Company. The Company will record charges associated with these payments and benefits during fiscal 2025.

SUBSEQUENT EVENT (Details) - Subsequent Event - Chief Financial Officer & Chief Administrative Officer $ in Thousands	Nov. 26, 2024 USD ($)
Subsequent Event [Line Items]
Salary payment term	24 months
Lump sum payment	$ 30
Lump sum payment term	24 months
Tranche One
Subsequent Event [Line Items]
Target bonus, payable percentage	50.00%
Tranche Two
Subsequent Event [Line Items]
Target bonus, payable percentage	50.00%

EQUITY - Restricted Share-Based Award Activity (Details) - Restricted Stock Units (RSUs) - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
No. of Units
Beginning Balance (in shares)	611,838
Granted (in shares)	363,264
Vested (in shares)	(77,826)
Forfeited (in shares)	(130,892)
Ending Balance (in shares)	766,384	611,838
Wtd. Avg. Grant Date Fair Value per Unit
Beginning Balance (USD per share)	$ 89.10
Granted (USD per share)	55.12	$ 59.48	$ 109.10
Vested (USD per share)	182.87
Forfeited (USD per share)	59.40
Ending Balance (USD per share)	$ 68.54	$ 89.10

EQUITY - Restricted Shares Issued to Vendor (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	363,264
Weighted average grant date fair value (in USD per share)	$ 55.12	$ 59.48	$ 109.10
Compensation costs net yet recognized	$ 9.9
Vendor
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	300,000	800,000
Weighted average grant date fair value (in USD per share)	$ 69.88	$ 52.44
Compensation costs net yet recognized	$ 20.0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

EQUITY - Share-Based Awards, Additional Information (Details) - USD ($) shares in Millions, $ in Millions	2 Months Ended	12 Months Ended
	Nov. 22, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Common share available for issue under share-based plan (in shares)		7.9
Common shares were available to underlie the grant of new share-based award (in shares)		3.6
Tax benefit realized from tax deduction associated with exercise of stock options and vesting of restricted share awards		$ (3.0)	$ (1.5)	$ 14.8
Treasury Shares
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Treasury shares reissued (in shares)		0.7	1.3	1.5
Share-Based Compensation Awards and Employee Stock Purchase Plan \| Treasury Shares
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Treasury shares reissued (in shares)		0.3	0.4	0.9
Restricted Stock Units, Performance Shares, And Stock Options
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Options and equity instruments other than options, grants in period (in shares)	0.3
Options and equity instruments other than options, grants in period, fair value	$ 9.8

EQUITY - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ (53.2)	$ (24.8)	$ (96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	52.2	76.4	2.6
Income tax benefit (expense)	6.5	(19.8)	15.6
Net current period other comprehensive income (loss)	5.5	31.8	(78.2)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(112.8)	(144.6)	(66.4)
Equity ending balance	(107.3)	(112.8)	(144.6)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(21.9)	(28.9)	(1.7)
Other comprehensive income (loss) before reclassifications	0.6	7.0	(27.2)
Amounts reclassified from accumulated other comprehensive net income (loss)	0.0	0.0	0.0
Income tax benefit (expense)	0.0	0.0	0.0
Net current period other comprehensive income (loss)	0.6	7.0	(27.2)
Equity ending balance	(21.3)	(21.9)	(28.9)
Net Unrealized Gain (Loss) On Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	20.1	33.3	10.2
Other comprehensive income (loss) before reclassifications	(10.6)	5.6	40.1
Amounts reclassified from accumulated other comprehensive net income (loss)	(9.7)	(23.3)	(9.1)
Income tax benefit (expense)	5.1	4.5	(7.9)
Net current period other comprehensive income (loss)	(15.2)	(13.2)	23.1
Equity ending balance	4.9	20.1	33.3
Net Unrealized Loss On Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(38.6)	(79.7)	(2.3)
Other comprehensive income (loss) before reclassifications	(40.4)	(34.9)	(102.0)
Amounts reclassified from accumulated other comprehensive net income (loss)	64.6	101.3	0.0
Income tax benefit (expense)	0.0	(25.3)	24.6
Net current period other comprehensive income (loss)	24.2	41.1	(77.4)
Equity ending balance	(14.4)	(38.6)	(79.7)
Pension and Other Post- Retirement Benefit Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(72.4)	(69.3)	(72.5)
Other comprehensive income (loss) before reclassifications	(2.8)	(2.5)	(7.3)
Amounts reclassified from accumulated other comprehensive net income (loss)	(2.7)	(1.6)	11.7
Income tax benefit (expense)	1.4	1.0	(1.1)
Net current period other comprehensive income (loss)	(4.1)	(3.1)	3.3
Equity ending balance	$ (76.5)	$ (72.4)	$ (69.3)

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 9.6	$ 15.1
Common shares, stated value per share (USD per share)	$ 0.01	$ 0.01
Common shares outstanding (in shares)	57.1	56.5
Treasury shares, at cost (in shares)	11.0	11.6

CONTINGENCIES (Details) $ in Millions	Sep. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Accrued liabilities related to other regulatory matters which are accounted for in the Other liabilities	$ 2.6

DEBT - Weighted Average Interest Rate (Details)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt, weighted average interest rate (percentage)	5.80%	5.40%	3.60%

EQUITY

12 Months Ended

Sep. 30, 2024

Equity [Abstract]

EQUITY

EQUITY (DEFICIT)

Authorized and issued shares consisted of the following (in millions):


	September 30,
	2024	2023

Preferred shares, no par value:
Authorized	0.2 shares	0.2 shares
Issued	0.0 shares	0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized	100.0 shares	100.0 shares
Issued	68.1 shares	68.1 shares

In fiscal 1995, The Scotts Company merged with Stern’s Miracle-Gro Products, Inc. (“Miracle-Gro”). At September 30, 2024, the former shareholders of Miracle-Gro, including the Hagedorn Partnership, L.P., owned approximately 24% of Scotts Miracle-Gro’s outstanding Common Shares and, therefore, have the ability to significantly influence the election of directors and other actions requiring the approval of Scotts Miracle-Gro’s shareholders.

Under the terms of the merger agreement with Miracle-Gro, the former shareholders of Miracle-Gro may not collectively acquire, directly or indirectly, beneficial ownership of Voting Stock (as that term is defined in the Miracle-Gro merger agreement) representing more than 49% of the total voting power of the outstanding Voting Stock, except pursuant to a tender offer for 100% of that total voting power, which tender offer is made at a price per share which is not less than the market price per share on the last trading day before the announcement of the tender offer and is conditioned upon the receipt of at least 50% of the Voting Stock beneficially owned by shareholders of Scotts Miracle-Gro other than the former shareholders of Miracle-Gro and their affiliates and associates.

Accumulated Other Comprehensive Loss

Changes in AOCL by component were as follows for the fiscal years ended September 30:


	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Loss On Securities		Pension and Other Post- Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2021	$	(1.7)	$	10.2	$	(2.3)	$	(72.5)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(27.2)		40.1		(102.0)		(7.3)		(96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.1)		—		11.7		2.6
Income tax benefit (expense)	—		(7.9)		24.6		(1.1)		15.6
Net current period other comprehensive income (loss)	(27.2)		23.1		(77.4)		3.3		(78.2)
Balance at September 30, 2022	(28.9)		33.3		(79.7)		(69.3)		(144.6)
Other comprehensive income (loss) before reclassifications	7.0		5.6		(34.9)		(2.5)		(24.8)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(23.3)		101.3		(1.6)		76.4
Income tax benefit (expense)	—		4.5		(25.3)		1.0		(19.8)
Net current period other comprehensive income (loss)	7.0		(13.2)		41.1		(3.1)		31.8
Balance at September 30, 2023	(21.9)		20.1		(38.6)		(72.4)		(112.8)
Other comprehensive income (loss) before reclassifications	0.6		(10.6)		(40.4)		(2.8)		(53.2)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.7)		64.6		(2.7)		52.2
Income tax benefit (expense)	—		5.1		—		1.4		6.5
Net current period other comprehensive income (loss)	0.6		(15.2)		24.2		(4.1)		5.5
Balance at September 30, 2024	$	(21.3)	$	4.9	$	(14.4)	$	(76.5)	$	(107.3)

The sum of the components may not equal due to rounding.

Share Repurchases

On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020 through March 25, 2023. There were no share repurchases under this share repurchase authorization during fiscal 2023 through its expiration on March 25, 2023. During fiscal 2022, Scotts Miracle-Gro repurchased 1.1 million Common Shares under this share repurchase authorization for $175.0. Treasury share purchases also include cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $5.1, $9.3 and $82.9 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Share-Based Awards

In January 2024, the shareholders of Scotts Miracle-Gro approved an amendment and restatement of The Scotts Miracle-Gro Company Long-Term Incentive Plan. As of September 30, 2024, the Company is authorized under this plan to grant up to approximately 7.9 million Common Shares, which includes an estimate of the number of Common Shares subject to outstanding awards under the plan that terminate, expire, or are cancelled, forfeited, exchanged, or surrendered without having been exercised, vested, or paid. At September 30, 2024, approximately 3.6 million Common Shares were not subject to outstanding awards and were available to underlie the grant of new share-based awards. Common Shares held in treasury totaling 0.3 million, 0.4 million and 0.9 million were reissued in support of share-based compensation awards under this plan and employee purchases under the employee stock purchase plan during fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Subsequent to September 30, 2024, the Company awarded stock options representing 0.3 million Common Shares to associates with an estimated grant date fair value of $9.8.

Total share-based compensation was as follows for each of the periods indicated:


	Year Ended September 30,
	2024		2023		2022

Share-based compensation	$	79.8	$	68.1	$	30.3
Related tax benefit recognized	14.8		15.6		4.9

Excess tax benefit (tax deficiency) related to share-based compensation was $(3.0), $(1.5) and $14.8 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Stock Options

Stock option activity was as follows:


	No. of Options	Wtd. Avg. Exercise Price		Wtd Avg Remaining Life	Aggregate Intrinsic Value
Awards outstanding at September 30, 2023	1,191,183	$	76.64	6.6 years
Granted	1,356,698	53.75
Exercised	(35,027)	58.52
Forfeited	(135,182)	55.69
Awards outstanding at September 30, 2024	2,377,672	65.03		7.5 years	$	71.4
Exercisable	493,832	108.97		2.6 years	8.9

The weighted average fair value per share of each option granted during fiscal 2024 and fiscal 2023 was $15.25 and $14.25, respectively. There were no options granted during fiscal 2022. The total intrinsic value of options exercised during fiscal 2024 was $0.6. There were no options exercised during fiscal 2023 or fiscal 2022. As of September 30, 2024, there was $9.4 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options that is expected to be recognized over a weighted-average period of 2.0 years. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $3.8, $2.3 and $3.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The weighted average assumptions used in the estimation of fair value for awards granted in fiscal 2024 are as follows:



Expected volatility	38.8	%
Risk-free interest rate	4.7	%
Expected dividend yield	4.1	%
Expected life	6.1 years

Restricted share-based awards

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit








Awards outstanding at September 30, 2023	611,838	$	89.10
Granted	363,264	55.12
Vested	(77,826)	182.87
Forfeited	(130,892)	59.40
Awards outstanding at September 30, 2024	766,384	68.54

The weighted-average grant-date fair value of restricted stock-based awards granted during fiscal 2024, fiscal 2023 and fiscal 2022 was $55.12, $59.48 and $109.10 per share, respectively. As of September 30, 2024, there was $9.9 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted stock-based awards that is expected to be recognized over a weighted-average period of 1.7 years. The total fair value of restricted stock units and deferred stock units vested during fiscal 2024, fiscal 2023 and fiscal 2022 was $4.6, $11.2 and $28.2, respectively.

Performance-based awards

Performance-based award activity was as follows (based on target award amounts):


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit








Awards outstanding at September 30, 2023	544,790	$	76.85
Granted	240,677	74.57
Vested (a)	(181,791)	59.88
Forfeited	(194,246)	65.89
Awards outstanding at September 30, 2024	409,430	86.61

(a)Vested at a weighted average of 100% of the target performance share units granted.

The weighted-average grant-date fair value of performance-based award units granted during fiscal 2024, fiscal 2023 and fiscal 2022 was $74.57, $66.00 and $132.74 per share, respectively. As of September 30, 2024, there was $7.6 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based award units that is expected to be recognized over a weighted-average period of 2.1 years. The total fair value of performance-based award unit vested during fiscal 2024, fiscal 2023 and fiscal 2022 was $10.6, $17.4 and $182.5, respectively.

During fiscal 2024, the Company granted performance-based award units with a three-year vesting period that include a performance target based on the Company’s total shareholder return relative to a Company selected peer group, among other financial targets. Details of the assumptions used in the estimation of fair value for these awards are as follows:



Expected volatility	36.6	%
Risk-free interest rate	4.5	%

For fiscal 2024, the Company is granting short-term equity incentive compensation awards to certain associates in the form of performance-based award units in lieu of cash-based annual incentive awards. Subsequent to September 30, 2024, awards representing 0.3 million Common Shares were granted and vested on the incentive payout date. The number of performance-based award units that the Company ultimately issued to participating associates was based on the incentive payout amount determined for each employee that was then converted into a variable number of performance-based award units based on the fair value of the Common Shares on the grant date. The awards were classified as liability awards and, as of September 30, 2024, the Company had accrued $20.2 in the “Other current liabilities” line in the Consolidated Balance Sheets and there was $0.0 unrecognized pre-tax compensation cost associated with these awards. The units associated with these awards are excluded from the table above.

Restricted shares issued to vendor

During fiscal 2024 and fiscal 2023, the Company issued 0.3 million and 0.8 million restricted shares, respectively, with a weighted-average grant date fair value of $69.88 and $52.44 per share, respectively, out of its treasury shares to a vendor in exchange for advertising services. As of September 30, 2024, there was $20.0 of total unrecognized pre-tax compensation cost related to these restricted shares that is expected to be recognized during fiscal 2025, when the services are performed.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

+ Details

EARNINGS PER COMMON SHARE - Additional Information (Details) - shares shares in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average number of shares outstanding, diluted (in shares)	56.8	56.0	55.5
Dilutive potential Common Shares (in shares)	0.0	0.0	0.0
Number of common shares covered by out-of-the-money stock options (in shares)	0.9	0.4	0.6
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of common shares covered by out-of-the-money stock options (in shares)	0.4	0.4	0.2

MARKETING AGREEMENT

12 Months Ended

Sep. 30, 2024

Marketing Agreement [Abstract]

MARKETING AGREEMENT

The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries. The annual commission payable under the Third Restated Agreement is equal to 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business for each program year in the markets covered by the Third Restated Agreement (“Program EBIT”). The Third Restated Agreement also requires the Company to make annual payments of $18.0 to Monsanto as a contribution against the overall expenses of its consumer Roundup® business, subject to reduction pursuant to the Third Restated Agreement for any program year in which the Program EBIT does not equal or exceed $36.0.

Unless Monsanto terminates the Third Restated Agreement due to an event of default by the Company, termination rights under the Third Restated Agreement include the following:

•The Company may terminate the Third Restated Agreement upon the insolvency or bankruptcy of Monsanto;

•Monsanto may terminate the Third Restated Agreement in the event that Monsanto decides to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Termination”); and

•Each party may terminate the Third Restated Agreement if Program EBIT falls below $50.0 and, in such case, no termination fee would be payable to either party.

The termination fee structure requires Monsanto to pay a termination fee to the Company in an amount equal to (i) $375.0 upon a Brand Decommissioning Termination, and (ii) the greater of $175.0 or four times an amount equal to the average of the Program EBIT for the three program years before the year of termination, minus $186.4, if Monsanto or its successor terminates the Third Restated Agreement as a result of a Roundup Sale or Change of Control of Monsanto (each, as defined in the Third Restated Agreement).

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Consolidated Statements of Operations are as follows:


	Year Ended September 30
	2024		2023		2022

Gross commission	$	90.8	$	75.7	$	83.4
Contribution expenses	(18.0)		(18.0)		(18.0)

Net commission	72.8		57.7		65.4
Reimbursements associated with Roundup® marketing agreement	91.2		82.5		67.9
Total net sales associated with Roundup® marketing agreement	$	164.0	$	140.2	$	133.3

INCOME TAXES - Domestic and Foreign Components of Income From Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Domestic	$ (10.8)	$ (376.2)	$ (427.3)
Foreign	(12.8)	(77.1)	(130.8)
Loss before income taxes	$ (23.6)	$ (453.3)	$ (558.1)

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Sep. 30, 2024

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation and Qualifying Accounts

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2024


Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	116.4	$	—	$	3.7	$	(108.6)	$	11.5
Income tax valuation allowance	87.7		3.6		13.7		(8.5)		96.5

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2023


Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	14.4	$	—	$	109.6	$	(7.6)	$	116.4
Income tax valuation allowance	40.7		9.5		37.8		(0.3)		87.7

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2022


Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Additions Other		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for expected credit losses	$	16.8	$	—	$	5.8	$	(8.2)	$	14.4
Income tax valuation allowance	32.3		—		9.0		(0.6)		40.7

LEASES (Tables)

12 Months Ended

Sep. 30, 2024

Leases [Abstract]

Supplemental Balance Sheet Information Schedule and Weighted-average remaining lease term

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	September 30, 2024		September 30, 2023

Operating leases:
Right-of-use assets	Other assets	$	265.4	$	262.6

Current lease liabilities	Other current liabilities	75.3		76.4
Non-current lease liabilities	Other liabilities	215.8		220.1
Total operating lease liabilities		$	291.1	$	296.5

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	15.2	$	14.5

Current lease liabilities	Current portion of debt	2.6		1.9
Non-current lease liabilities	Long-term debt	15.2		15.0
Total finance lease liabilities		$	17.8	$	16.9

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	5.2		5.4
Finance leases	8.1		9.5

Weighted-average discount rate:
Operating leases	5.9	%	5.2	%
Finance leases	4.7	%	4.4	%

Components of lease cost

Components of lease cost were as follows:


	Year Ended September 30,
	2024		2023		2022

Operating lease cost (a)	$	85.8	$	92.3	$	86.7
Variable lease cost	30.3		28.6		35.9


Finance lease cost
Amortization of right-of-use assets	2.6		3.0		6.4
Interest on lease liabilities	0.8		0.8		1.2
Total finance lease cost	$	3.4	$	3.8	$	7.6

(a)Operating lease cost includes amortization of right-of-use assets of $70.4, $81.0 and $75.3 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Short-term lease expense is excluded from operating lease cost and was $6.1, $6.6 and $19.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Year Ended September 30,
	2024		2023		2022

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	99.2	$	93.0	$	83.9
Operating cash flows from finance leases	0.8		0.8		1.2
Financing cash flows from finance leases	2.3		2.7		5.9

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	77.0	$	90.4	$	71.9
Finance leases	3.4		—		1.5

Maturities of Operating Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:


Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

Maturities of Finance Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:


Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
Cost of sales	2,618.7	2,708.3	2,891.1
Cost of sales—impairment, restructuring and other	83.5	185.7	160.1
Gross margin	850.5	657.3	872.9
Operating expenses:
Selling, general and administrative	559.0	551.3	613.0
Impairment, restructuring and other	62.8	280.5	693.1
Other (income) expense, net	19.9	(0.1)	0.8
Income (loss) from operations	208.8	(174.4)	(434.0)
Equity in loss of unconsolidated affiliates	68.1	101.1	12.9
Interest expense	158.8	178.1	118.1
Other non-operating (income) expense, net	5.5	(0.3)	(6.9)
Loss before income taxes	(23.6)	(453.3)	(558.1)
Income tax expense (benefit)	11.3	(73.2)	(120.6)
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Basic net loss per common share
Basic net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)
Diluted net loss per common share
Diluted net income (loss) per common share (USD per share)	$ (0.61)	$ (6.79)	$ (7.88)

ASSOCIATE MEDICAL BENEFITS - Expected Benefit Payments Under the Plan By The Company and Retirees (Details) $ in Millions	Sep. 30, 2024 USD ($)
Gross Benefit Payments
Defined Benefit Plan Disclosure [Line Items]
2025	$ 1.6
2026	1.8
2027	1.9
2028	2.0
2029	2.1
2030 – 2034	9.5
Retiree Contribution
Defined Benefit Plan Disclosure [Line Items]
2025	0.3
2026	0.4
2027	0.6
2028	0.7
2029	0.7
2030 – 2034	3.7
Net Company Payments
Defined Benefit Plan Disclosure [Line Items]
2025	1.3
2026	1.3
2027	1.4
2028	1.3
2029	1.3
2030 – 2034	$ 5.7

INCOME TAXES - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2021
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Net of Valuation Allowance	$ 309.2	$ 323.4
Deferred Tax Assets, Valuation Allowance	(96.5)	(87.7)
Convertible debt investments	43.6	33.4
Foreign tax credit carryovers	15.2	16.3
Deferred tax assets subject to limitation	9.9	10.5
Statutory tax benefit of net operating loss carryovers and related valuation allowances	9.7	10.2
Net operating loss carryovers	56.4	67.3
Gross unrecognized tax benefits	25.7	34.6	$ 35.8	$ 24.1
Unrecognized tax benefits that would have an impact on the effective tax rate	23.1	31.1	31.5
Unrecognized tax benefits accrued payment of interest	5.8	3.9	3.2
Unrecognized tax benefits accrued payment of penalties	1.1	1.3	$ 1.6
Other assets
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Net of Valuation Allowance	191.3	189.8
Other liabilities
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Liabilities, Net	7.0	1.1
Foreign Country
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Valuation Allowance	(4.6)	(6.4)
Foreign tax credit carryovers	15.2	16.3
Deferred Tax Assets, Operating Loss Carryforwards, Foreign	6.8	8.3
U.S. state and local tax authorities
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Valuation Allowance	(7.0)	(6.9)
State tax credit carryovers	1.0	1.4
Valuation allowance for state credits	0.8	1.3
State net operating losses carryforward	$ 19.1	15.2
State net operating losses carryforward period, minimum	5 years
Valuation allowance related to other state items	$ 2.6	2.2
Domestic Tax Authority
Investments, Owned, Federal Income Tax Note [Line Items]
Net operating loss carryovers	20.6
Foreign Tax Jurisdiction, Other
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Valuation Allowance	$ (13.0)	$ (11.0)

RETIREMENT PLANS - Benefit Obligations, Plan Assets, Annual Expense, Assumptions and Other Information of the Company's Defined Benefit Pension Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	$ 62.7	$ 64.1
Non-current liabilities	(73.0)	(76.7)
International Plan \| Defined Benefit Pension Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	108.5	109.2
Interest cost	5.9	6.2
Actuarial (gain) loss	5.1	(11.0)
Benefits paid	(6.6)	(5.9)
Foreign currency translation	10.3	10.0
Projected benefit obligation (“PBO”) at end of year	123.2	108.5
Accumulated benefit obligation (“ABO”) at end of year	123.2	108.5
Change in plan assets:
Fair value of plan assets at beginning of year	124.8	128.9
Actual return on plan assets	10.0	(11.5)
Employer contribution	0.9	1.2
Benefits paid	(6.6)	(5.9)
Foreign currency translation	12.3	12.1
Fair value of plan assets at end of year	141.4	124.8
Overfunded (underfunded) status at end of year	18.2	16.3
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	12.0	11.5
Fair value of plan assets	0.0	0.0
Projected benefit obligation	12.0	11.5
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	30.2	27.8
Current liabilities	(0.9)	(0.9)
Non-current liabilities	(11.1)	(10.6)
Total amount accrued	18.2	16.3
Amounts recognized in AOCL consist of:
Actuarial loss	64.1	60.0
Prior service cost	2.3	2.1
Total amount recognized	66.4	62.1
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	(0.7)	(6.0)
Reclassification to net earnings	2.3	2.0
Foreign currency translation	(5.9)	(4.8)
Total change in other comprehensive loss	$ (4.3)	$ (8.8)
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.86%	5.38%
U.S. Plan \| Defined Benefit Pension Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	$ 71.8	$ 77.7
Interest cost	3.7	3.6
Actuarial (gain) loss	5.5	(2.5)
Benefits paid	(6.8)	(6.9)
Foreign currency translation	0.0	0.0
Projected benefit obligation (“PBO”) at end of year	74.2	71.8
Accumulated benefit obligation (“ABO”) at end of year	74.2	71.8
Change in plan assets:
Fair value of plan assets at beginning of year	54.1	59.1
Actual return on plan assets	7.1	1.7
Employer contribution	2.9	0.2
Benefits paid	(6.8)	(6.9)
Foreign currency translation	0.0	0.0
Fair value of plan assets at end of year	57.3	54.1
Overfunded (underfunded) status at end of year	(16.9)	(17.7)
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	74.2	71.8
Fair value of plan assets	57.3	54.1
Projected benefit obligation	74.2	71.8
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	0.0	0.0
Current liabilities	(0.2)	(0.2)
Non-current liabilities	(16.7)	(17.5)
Total amount accrued	(16.9)	(17.7)
Amounts recognized in AOCL consist of:
Actuarial loss	34.1	35.2
Prior service cost	0.0	0.0
Total amount recognized	34.1	35.2
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	(0.5)	1.8
Reclassification to net earnings	1.7	1.8
Foreign currency translation	0.0	0.0
Total change in other comprehensive loss	$ 1.2	$ 3.6
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.62%	5.54%

Audit Information	12 Months Ended
Audit Information	Sep. 30, 2024
Audit Information [Abstract]
Auditor Firm ID	34
Auditor Location	Columbus, Ohio
Auditor Name	DELOITTE & TOUCHE LLP

DEBT - Credit Facilities (Details) $ in Millions			12 Months Ended
DEBT - Credit Facilities (Details) $ in Millions	Jul. 31, 2023 USD ($)	Apr. 08, 2022 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023	Sep. 30, 2022	Jun. 08, 2022
Debt Instrument [Line Items]
Debt, weighted average interest rate (percentage)			5.80%	5.40%	3.60%
Fixed charge coverage ratio			1.27
Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Fixed charge coverage ratio, minimum			1.00
Debt Instrument, Redemption, Period Five
Debt Instrument [Line Items]
Maximum leverage ratio			6.00
Debt Instrument, Redemption, Period Six
Debt Instrument [Line Items]
Maximum leverage ratio			5.50
Debt Instrument, Redemption, Period Seven
Debt Instrument [Line Items]
Maximum leverage ratio			5.25
Debt Instrument, Redemption, Period Eight
Debt Instrument [Line Items]
Maximum leverage ratio			5.00
Debt Instrument, Redemption, Period Nine
Debt Instrument [Line Items]
Maximum leverage ratio			4.75
Debt Instrument, Redemption, Period Ten
Debt Instrument [Line Items]
Maximum leverage ratio			4.50
Fifth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Leverage ratio			4.86
Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 2,500.0
Outstanding debt			$ 2,225.0
Credit Facilities
Debt Instrument [Line Items]
Senior secured credit facilities, available borrowing capacity			$ 1,167.0
Credit Facilities \| Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Debt, maturity period (in years)		5 years
Revolving loans
Debt Instrument [Line Items]
Debt, weighted average interest rate (percentage)			9.10%	7.60%	2.80%
Revolving loans \| Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One
Debt Instrument [Line Items]
Interest rate, increase (decrease)						35
Annual facility fee rate increase (decrease)						15
Maximum leverage ratio						4.75
Cash dividends, annual maximum	$ 225.0
Maximum other dividends and distributions	25.0
Revolving loans \| Sixth Amended And Restated Senior Secured Credit Agreement, Amendment Two
Debt Instrument [Line Items]
Line Of Credit Facility, Commitment, Increase (Decrease)	$ 250.0
Debt Instrument, Interest Rate, Increase (Decrease)	0.25%
Debt Instrument, Covenant, Leverage Ratio, Minimum Threshold For Additional Pricing Tier	6.00
Debt Instrument, Covenant, Incremental Investments, Loans, And Advances, Maximum	$ 25.0
Letter of Credit \| Credit Facilities
Debt Instrument [Line Items]
Aggregate face amount of letters of credit outstanding			$ 83.0
Term loans \| Credit Facilities
Debt Instrument [Line Items]
Repayments of debt			$ 250.0
Revolving loans \| Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 1,500.0
Letters of credit		100.0
Secured Term Loan \| Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 1,000.0
Secured Term Loan \| Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One
Debt Instrument [Line Items]
Interest rate, increase (decrease)						50

RETIREMENT PLANS

12 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

RETIREMENT PLANS

The Company sponsors a defined contribution 401(k) plan for substantially all U.S. associates. The Company matches 200% of associates’ initial 3% contribution and 50% of their remaining contribution up to 6%. The Company may make additional discretionary profit sharing matching contributions to eligible associates on their initial 4% contribution. The Company recorded expenses of $23.7, $24.1 and $28.3 associated with the plan in fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The Company sponsors two defined benefit pension plans for certain U.S. associates and three defined benefit pension plans associated with the former businesses in the United Kingdom and Germany. Benefits under these plans have been frozen and closed to new associates since 1997 for the U.S. plans, 2010 for the United Kingdom plans and 2017 for the Germany plan. The benefits under the plans are based on years of service and compensation levels. The Company’s funding policy for the defined benefit pension plans, consistent with statutory requirements and tax considerations, is based on actuarial computations using the Projected Unit Credit method.

During fiscal 2023 and 2021, the defined benefit pension plans associated with the former business in the United Kingdom entered into buy-in insurance policies in exchange for premium payments of $76.3 and $67.7, respectively, which are subject to adjustment as a result of subsequent data cleansing activities. Under the terms of these buy-in insurance policies, the respective insurers are liable to pay the benefits to the plans, but the plans still retain full legal responsibility to pay benefits to plan participants using the insurance payments. The buy-in policies will be treated as assets of the plans going forward until such time as the buy-in policies are converted to buy-out policies, which is when individual insurance policies will be assigned to each plan participant and the plans will no longer have legal responsibility to pay the benefits to the plan participants.

The following tables present information about benefit obligations, plan assets, annual expense, assumptions and other information about the Company’s defined benefit pension plans. The defined benefit pension plans are valued using a September 30 measurement date.


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023

Change in projected benefit obligation:
Benefit obligation at beginning of year	$	71.8	$	77.7	$	108.5	$	109.2

Interest cost	3.7		3.6		5.9		6.2
Actuarial (gain) loss	5.5		(2.5)		5.1		(11.0)
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)





Foreign currency translation	—		—		10.3		10.0
Projected benefit obligation (“PBO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Accumulated benefit obligation (“ABO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Change in plan assets:
Fair value of plan assets at beginning of year	$	54.1	$	59.1	$	124.8	$	128.9
Actual return on plan assets	7.1		1.7		10.0		(11.5)
Employer contribution	2.9		0.2		0.9		1.2

Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)

Foreign currency translation	—		—		12.3		12.1

Fair value of plan assets at end of year	$	57.3	$	54.1	$	141.4	$	124.8
Overfunded (underfunded) status at end of year	$	(16.9)	$	(17.7)	$	18.2	$	16.3


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023

Information for pension plans with an ABO in excess of plan assets:

Accumulated benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Information for pension plans with a PBO in excess of plan assets:
Projected benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Amounts recognized in the Consolidated Balance Sheets consist of:

Non-current assets	$	—	$	—	$	30.2	$	27.8
Current liabilities	(0.2)		(0.2)		(0.9)		(0.9)
Non-current liabilities	(16.7)		(17.5)		(11.1)		(10.6)
Total amount accrued	$	(16.9)	$	(17.7)	$	18.2	$	16.3
Amounts recognized in AOCL consist of:
Actuarial loss	$	34.1	$	35.2	$	64.1	$	60.0
Prior service cost	—		—		2.3		2.1
Total amount recognized	$	34.1	$	35.2	$	66.4	$	62.1


	U.S. Defined Benefit Pension Plans						International Defined Benefit Pension Plans
	2024			2023			2024			2023

Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	$	(0.5)		$	1.8		$	(0.7)		$	(6.0)
Reclassification to net earnings	1.7			1.8			2.3			2.0



Foreign currency translation	—			—			(5.9)			(4.8)
Total change in other comprehensive loss	$	1.2		$	3.6		$	(4.3)		$	(8.8)




Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.62		%	5.54		%	4.86		%	5.38		%


	U.S. Defined Benefit Pension Plans									International Defined Benefit Pension Plans
	2024			2023			2022			2024			2023			2022

Components of net periodic benefit cost (income):

Interest cost	$	3.7		$	3.6		$	1.7		$	5.9		$	6.2		$	3.0
Expected return on plan assets	(2.2)			(2.5)			(2.8)			(5.7)			(5.5)			(5.1)
Net amortization	1.7			1.8			1.7			2.3			2.0			1.3
Net periodic benefit cost (income)	$	3.2		$	2.9		$	0.6		$	2.5		$	2.7		$	(0.8)




Weighted average assumptions used in development of net periodic benefit cost (income):


Weighted average discount rate - interest cost	5.46		%	4.87		%	1.74		%	5.38		%	5.29		%	1.64		%
Expected return on plan assets	4.25		%	4.50		%	3.50		%	4.42		%	3.91		%	2.37		%

Investment Strategy

Target allocation percentages among various asset classes are maintained based on an individual investment policy established for each of the various pension plans. Asset allocations are designed to achieve long-term objectives of return while mitigating against downside risk considering expected cash requirements necessary to fund benefit payments. However, the Company cannot predict future investment returns and therefore cannot determine whether future pension plan funding requirements could materially and adversely affect its financial condition, results of operations or cash flows.

Basis for Long-Term Rate of Return on Asset Assumptions

The Company’s expected long-term rate of return on asset assumptions are derived from studies conducted by third parties. The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings expected. While the studies give appropriate consideration to recent fund performance and historical returns, the assumptions primarily represent expectations about future rates of return over the long term.


	U.S. Defined Benefit Pension Plans			International Defined Benefit Pension Plans

Other information:
Plan asset allocations:
Target for September 30, 2025:
Equity securities	19		%	—		%
Debt securities	76		%	—		%
Real estate securities	3		%	—		%
Cash and cash equivalents	2		%	15		%
Insurance contracts	—		%	85		%
September 30, 2024
Equity securities	19		%	—		%
Debt securities	74		%	—		%
Real estate securities	2		%	—		%
Cash and cash equivalents	5		%	15		%
Insurance contracts	—		%	85		%
September 30, 2023
Equity securities	18		%	—		%
Debt securities	75		%	5		%
Real estate securities	3		%	—		%
Cash and cash equivalents	4		%	11		%
Insurance contracts	—		%	84		%

Expected company contributions in fiscal 2025	$	2.7		$	0.9
Expected future benefit payments:
2025	$	7.5		$	7.3
2026	7.0			7.4
2027	6.9			7.4
2028	6.7			7.6
2029	6.5			7.8
2030 – 2034	28.4			40.5

The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy:


	Fair Value Hierarchy Level	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
		2024		2023		2024		2023
Cash and cash equivalents	Level 1	$	2.6	$	2.2	$	21.9	$	14.0
Insurance contracts	Level 3	—		—		119.5		104.3
Total assets in the fair value hierarchy		$	2.6	$	2.2	$	141.4	$	118.3
Common collective trusts measured at net asset value
Real estate		$	1.4	$	1.8	$	—	$	—
Equities		10.9		10.0		—		—
Fixed income		42.4		40.1		—		6.5

Total common collective trusts measured at net asset value		54.7		51.9		—		6.5
Total assets at fair value		$	57.3	$	54.1	$	141.4	$	124.8

The carrying value of cash equivalents approximated their aggregate fair value as of September 30, 2024 and 2023. The valuation of the buy-in insurance policies was calculated on an insurer pricing basis updated for changes in market implied insurance pricing, market rates, and inflation, and was estimated using unobservable inputs. Common collective trusts are not publicly traded and were valued at a net asset value unit price determined by the portfolio’s sponsor based on the fair value of underlying assets held by the common collective trust on September 30, 2024 and 2023. The common collective trusts hold underlying investments that have prices derived from quoted prices in active markets. The underlying assets are principally marketable equity and fixed income securities.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 70
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480794/715-70-50-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480482/715-20-55-17

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/715/tableOfContent

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (o)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (p)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 60
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480266/715-60-50-3

+ Details

RETIREMENT PLANS - Fair Value of The Company's Pension Plan Asset (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
International Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 141.4	$ 124.8	$ 128.9
International Plan \| Fair Value, Inputs, Level 1 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	141.4	118.3
International Plan \| Fair value, inputs, level 1 \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	21.9	14.0
International Plan \| Fair value, inputs, level 3 \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	119.5	104.3
International Plan \| Total common collective trusts measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	6.5
International Plan \| Total common collective trusts measured at net asset value \| Common collective trusts—real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
International Plan \| Total common collective trusts measured at net asset value \| Common collective trusts—equities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
International Plan \| Total common collective trusts measured at net asset value \| Common collective trusts—fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	6.5
U.S. Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	57.3	54.1	$ 59.1
U.S. Plan \| Fair Value, Inputs, Level 1 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.6	2.2
U.S. Plan \| Fair value, inputs, level 1 \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.6	2.2
U.S. Plan \| Fair value, inputs, level 3 \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
U.S. Plan \| Total common collective trusts measured at net asset value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	54.7	51.9
U.S. Plan \| Total common collective trusts measured at net asset value \| Common collective trusts—real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1.4	1.8
U.S. Plan \| Total common collective trusts measured at net asset value \| Common collective trusts—equities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	10.9	10.0
U.S. Plan \| Total common collective trusts measured at net asset value \| Common collective trusts—fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 42.4	$ 40.1

LEASES - (Supplemental Cash Flow Information and Non-Cash Activity Schedule) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Lease, Cost [Abstract]
Operating cash flows from operating leases, net	$ 99.2	$ 93.0	$ 83.9
Operating cash flows from finance leases	0.8	0.8	1.2
Financing cash flows from finance leases	2.3	2.7	5.9
Right-of-use assets obtained in exchange for lease obligations, operating leases	77.0	90.4	71.9
Right-of-use assets obtained in exchange for lease obligations, finance leases	$ 3.4	$ 0.0	$ 1.5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($) shares in Millions, $ in Millions		6 Months Ended	12 Months Ended
	Sep. 04, 2024	Jul. 01, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Sep. 01, 2024	Oct. 27, 2023	Apr. 22, 2022
Significant Accounting Policies [Line Items]
Percentage of annual net sales from combined second and third quarter sales		75.00%
Number of restricted shares issued (in shares)	0.3
Deferred advertising costs			$ 20.0
Advertising expenses			141.0	$ 123.7	$ 120.3
Research and development charge			34.6	35.7	45.3
Product registration costs			9.0	12.4	13.0
Accounts Receivable, Held-for-Sale						$ 750.0	$ 600.0
Derecognition of net receivables			186.6
Proceeds from sale of net receivables			1,938.6
Total discount recorded on sale			24.6
Interest capitalized on capital projects			1.1	2.1	2.2
Noncash investing activities for unpaid liabilities incurred			16.3	32.1	33.3
Outstanding payment obligations			12.5	18.3
Supplier finance payment			245.5	185.3
Recognition of accumulated foreign currency translation (gain) loss			$ (0.4)	$ 1.3	1.3
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]			Other Liabilities, Current	Other Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]			Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Other investing, net			$ 2.6	$ (12.4)	29.3
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]			Accounts Payable, Current	Accounts Payable, Current
Investments in unconsolidated affiliates			$ (21.4)	$ 0.0	0.0
Proceeds from loans receivable			$ 0.0	$ 37.0	$ 0.0
RIV Capital, Inc. \| Convertible Notes Payable
Significant Accounting Policies [Line Items]
Aggregate principal amount								$ 25.0
Standby Letters of Credit
Significant Accounting Policies [Line Items]
Maximum borrowing capacity							$ 75.0
Performance-Based Units
Significant Accounting Policies [Line Items]
Award vesting period (in years)			3 years
Officer \| Options
Significant Accounting Policies [Line Items]
Expiration period (in years)			10 years
Director
Significant Accounting Policies [Line Items]
Award vesting period (in years)			1 year
Minimum
Significant Accounting Policies [Line Items]
Award vesting period (in years)			3 years
Expected forfeiture rate			15.00%
Intangible assets amortization period			3 years
Payment timing, period			30 days
Minimum \| Software
Significant Accounting Policies [Line Items]
Intangible assets amortization period			3 years
Minimum \| Officer \| Performance-Based Units
Significant Accounting Policies [Line Items]
Vesting percent of target award			0.00%
Maximum
Significant Accounting Policies [Line Items]
Intangible assets amortization period			25 years
Payment timing, period			60 days
Maximum \| Software
Significant Accounting Policies [Line Items]
Intangible assets amortization period			8 years
Maximum \| Officer \| Performance-Based Units
Significant Accounting Policies [Line Items]
Vesting percent of target award			325.00%

EQUITY - Dividends (Details) - $ / shares	12 Months Ended
EQUITY - Dividends (Details) - $ / shares	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Equity [Abstract]
Dividends declared (USD per share)	$ 2.64	$ 2.64	$ 2.64

COMMITMENTS

12 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS

At September 30, 2024, the Company had the following unconditional purchase obligations by purchase date that have not been recognized in the Consolidated Balance Sheet:


2025	$	310.9
2026	193.5
2027	79.2
2028	39.3
2029	24.6
Thereafter	33.7
	$	681.2

Purchase obligations primarily represent commitments for materials used in the Company’s manufacturing processes, including urea and packaging, as well as commitments for warehouse services, grass seed, marketing services and information technology services.

RETIREMENT PLANS (Tables)

12 Months Ended

Sep. 30, 2024

Retirement Benefits [Abstract]

Schedule of Defined Benefit Pension Plans

The defined benefit pension plans are valued using a September 30 measurement date.


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023

Change in projected benefit obligation:
Benefit obligation at beginning of year	$	71.8	$	77.7	$	108.5	$	109.2

Interest cost	3.7		3.6		5.9		6.2
Actuarial (gain) loss	5.5		(2.5)		5.1		(11.0)
Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)





Foreign currency translation	—		—		10.3		10.0
Projected benefit obligation (“PBO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Accumulated benefit obligation (“ABO”) at end of year	$	74.2	$	71.8	$	123.2	$	108.5
Change in plan assets:
Fair value of plan assets at beginning of year	$	54.1	$	59.1	$	124.8	$	128.9
Actual return on plan assets	7.1		1.7		10.0		(11.5)
Employer contribution	2.9		0.2		0.9		1.2

Benefits paid	(6.8)		(6.9)		(6.6)		(5.9)

Foreign currency translation	—		—		12.3		12.1

Fair value of plan assets at end of year	$	57.3	$	54.1	$	141.4	$	124.8
Overfunded (underfunded) status at end of year	$	(16.9)	$	(17.7)	$	18.2	$	16.3


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2024		2023		2024		2023

Information for pension plans with an ABO in excess of plan assets:

Accumulated benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Information for pension plans with a PBO in excess of plan assets:
Projected benefit obligation	$	74.2	$	71.8	$	12.0	$	11.5
Fair value of plan assets	57.3		54.1		—		—
Amounts recognized in the Consolidated Balance Sheets consist of:

Non-current assets	$	—	$	—	$	30.2	$	27.8
Current liabilities	(0.2)		(0.2)		(0.9)		(0.9)
Non-current liabilities	(16.7)		(17.5)		(11.1)		(10.6)
Total amount accrued	$	(16.9)	$	(17.7)	$	18.2	$	16.3
Amounts recognized in AOCL consist of:
Actuarial loss	$	34.1	$	35.2	$	64.1	$	60.0
Prior service cost	—		—		2.3		2.1
Total amount recognized	$	34.1	$	35.2	$	66.4	$	62.1


	U.S. Defined Benefit Pension Plans						International Defined Benefit Pension Plans
	2024			2023			2024			2023

Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	$	(0.5)		$	1.8		$	(0.7)		$	(6.0)
Reclassification to net earnings	1.7			1.8			2.3			2.0



Foreign currency translation	—			—			(5.9)			(4.8)
Total change in other comprehensive loss	$	1.2		$	3.6		$	(4.3)		$	(8.8)




Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.62		%	5.54		%	4.86		%	5.38		%

Components of Net Periodic Benefit Cost


	U.S. Defined Benefit Pension Plans									International Defined Benefit Pension Plans
	2024			2023			2022			2024			2023			2022

Components of net periodic benefit cost (income):

Interest cost	$	3.7		$	3.6		$	1.7		$	5.9		$	6.2		$	3.0
Expected return on plan assets	(2.2)			(2.5)			(2.8)			(5.7)			(5.5)			(5.1)
Net amortization	1.7			1.8			1.7			2.3			2.0			1.3
Net periodic benefit cost (income)	$	3.2		$	2.9		$	0.6		$	2.5		$	2.7		$	(0.8)




Weighted average assumptions used in development of net periodic benefit cost (income):


Weighted average discount rate - interest cost	5.46		%	4.87		%	1.74		%	5.38		%	5.29		%	1.64		%
Expected return on plan assets	4.25		%	4.50		%	3.50		%	4.42		%	3.91		%	2.37		%

Schedule of Other Information


	U.S. Defined Benefit Pension Plans			International Defined Benefit Pension Plans

Other information:
Plan asset allocations:
Target for September 30, 2025:
Equity securities	19		%	—		%
Debt securities	76		%	—		%
Real estate securities	3		%	—		%
Cash and cash equivalents	2		%	15		%
Insurance contracts	—		%	85		%
September 30, 2024
Equity securities	19		%	—		%
Debt securities	74		%	—		%
Real estate securities	2		%	—		%
Cash and cash equivalents	5		%	15		%
Insurance contracts	—		%	85		%
September 30, 2023
Equity securities	18		%	—		%
Debt securities	75		%	5		%
Real estate securities	3		%	—		%
Cash and cash equivalents	4		%	11		%
Insurance contracts	—		%	84		%

Expected company contributions in fiscal 2025	$	2.7		$	0.9
Expected future benefit payments:
2025	$	7.5		$	7.3
2026	7.0			7.4
2027	6.9			7.4
2028	6.7			7.6
2029	6.5			7.8
2030 – 2034	28.4			40.5

Fair Value of The Company's Pension Plan Asset

The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy:


	Fair Value Hierarchy Level	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
		2024		2023		2024		2023
Cash and cash equivalents	Level 1	$	2.6	$	2.2	$	21.9	$	14.0
Insurance contracts	Level 3	—		—		119.5		104.3
Total assets in the fair value hierarchy		$	2.6	$	2.2	$	141.4	$	118.3
Common collective trusts measured at net asset value
Real estate		$	1.4	$	1.8	$	—	$	—
Equities		10.9		10.0		—		—
Fixed income		42.4		40.1		—		6.5

Total common collective trusts measured at net asset value		54.7		51.9		—		6.5
Total assets at fair value		$	57.3	$	54.1	$	141.4	$	124.8

EQUITY - Schedule of Share-Based Compensation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Equity [Abstract]
Share-based compensation	$ 79.8	$ 68.1	$ 30.3
Related tax benefit recognized	$ 14.8	$ 15.6	$ 4.9

FAIR VALUE MEASUREMENTS

12 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following describes the valuation methodologies used for financial assets and liabilities measured or disclosed at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.

Cash Equivalents

Cash equivalents consist of highly liquid financial instruments with original maturities of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.

Other

Investment securities in non-qualified retirement plan assets are valued using observable market prices in active markets.

The fair values of convertible debt investments are determined using scenario-based internally developed valuation models that consider a probability-weighted assessment of possible future cash flows related to the debt component and the conversion component of the instruments, discounted to present value using an appropriate discount rate. The probability of amendments to federal laws in the United States to allow for the general cultivation, distribution, and possession of cannabis, and the impact of such amendments on the value of the underlying investments are important assumptions in the fair value estimates. The valuation models and related assumptions require significant judgment. These and other assumptions are impacted by economic conditions and expectations of management and may change in the future based on period specific facts and circumstances.

Debt Instruments

Debt instruments are recorded at cost. The interest rate on borrowings under the Sixth A&R Credit Agreement fluctuates in accordance with the terms of the Sixth A&R Credit Agreement and thus the carrying value is a reasonable estimate of fair value. The fair values of the 4.000% Senior Notes, 4.375% Senior Notes, 4.500% Senior Notes and 5.250% Senior Notes are determined based on quoted market prices.

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:


		2024				2023
	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	51.2	$	51.2	$	1.2	$	1.2




Other
Investment securities in non-qualified retirement plan assets	Level 1	32.4		32.4		36.3		36.3

Convertible debt investments	Level 3	45.8		45.8		85.8		85.8

Liabilities




Debt instruments
Credit facilities – revolving loans	Level 2	—		—		88.3		88.3
Credit facilities – term loans	Level 2	625.0		625.0		925.0		925.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		456.3		500.0		380.0
Senior Notes due 2032 – 4.375%	Level 2	400.0		370.0		400.0		304.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		432.0		450.0		366.8
Senior Notes due 2026 – 5.250%	Level 2	250.0		248.8		250.0		233.1



Other debt	Level 2	—		—		0.4		0.4

Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.


	Year Ended September 30,
	2024		2023
Fair value at beginning of year	$	85.8	$	117.0

Total realized / unrealized gains (losses) included in net earnings	(64.2)		(97.6)
Total realized / unrealized gains / losses included in / reclassified from OCI	24.2		66.4
Fair value at end of year	$	45.8	$	85.8

Convertible debt investments include, among other minority non-equity investments, convertible notes issued to The Hawthorne Collective, Inc. (“THC”), a wholly-owned subsidiary of the Company, by RIV Capital (CSE: RIV) (OTC: CNPOF). Assuming full conversion of the RIV Capital convertible notes, THC would be entitled to receive approximately 123.0 million common shares of RIV Capital, representing approximately 47% of RIV Capital’s outstanding shares as of September 30, 2024. The RIV Capital convertible notes are convertible into common shares of RIV Capital either (i) at the election of THC or (ii) at the election of RIV Capital after the date on which federal laws in the United States are amended to allow for the general cultivation, distribution, and possession of cannabis. In connection with issuance of the RIV Capital convertible notes, the Company entered into an investor rights agreement with RIV Capital providing for, among other things, customary registration rights, participation rights, as well as certain standstill and transfer restrictions. In addition, THC is entitled to designate three nominees to the RIV Capital board of directors for so long as the board is comprised of seven directors, and will be entitled to designate four nominees to the RIV Capital board of directors if the size of the board is increased to nine directors. The Company or THC will not have control of or an active day-to-day role in any entity in which THC has a convertible debt investment. The convertible notes include restrictions that the funds received from the Company will be used for general corporate and other lawful purposes, which could include acquisitions, and that the funds will not be used in connection with or for any cannabis or cannabis-related operations in the U.S. unless and until such operations comply with all applicable U.S. federal laws.

During fiscal 2023, the Company recognized a non-cash, pre-tax other-than-temporary impairment charge related to its convertible debt investments of $101.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. This charge was driven by revisions to the Company’s internal forecasts of cash flows expected to be collected from its convertible debt investments resulting from the accumulation of adverse conditions impacting the cannabis market, including both federal and state level regulatory considerations and persistent industry oversupply conditions.

On May 30, 2024, RIV Capital and Cansortium Inc. (“Cansortium”) (CSE: TIUM.U) (OTCQB: CNTMF) announced they have entered into a definitive agreement pursuant to which Cansortium will acquire all of the issued and outstanding common shares of RIV Capital in exchange for Cansortium shares (the “Transaction”). The closing of the Transaction is subject to various conditions, including shareholder and court approvals, the receipt of all required regulatory approvals, and the exchange of THC’s existing convertible debt investment in RIV Capital for a new class of non-voting exchangeable shares of Cansortium. These exchangeable shares would be convertible, at THC’s discretion, into approximately 23% of the common shares of Cansortium on a pro forma basis as of the closing of the Transaction. During the fourth quarter of fiscal 2024, the shareholders of RIV Capital and Cansortium voted in favor of the resolutions associated with the Transaction. At September 30, 2024, the Company concluded it had the intent to exchange its RIV Capital convertible notes for non-voting exchangeable shares of Cansortium in connection with the Transaction, and remeasured the investment at the fair value of the non-voting exchangeable shares that the Company expects to receive. This resulted in the recognition of a non-cash, pre-tax other-than-temporary impairment charge of $64.6 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. In addition, the previously recorded allowance for credit losses associated with the RIV Capital convertible notes of $99.4 was written off and the amortized cost basis was written down to the investment’s fair value.

The amortized cost basis of convertible debt investments was $62.1 and $225.8 at September 30, 2024 and 2023, respectively. At September 30, 2024 and 2023, gross unrealized losses on convertible debt investments were $16.4 and $140.0, respectively, and there were no gross unrealized gains. These investments have been in a continuous unrealized loss position for greater than 12 months as of September 30, 2024. The allowance for expected credit losses was $1.9 and $101.3 at September 30, 2024 and 2023, respectively. At September 30, 2024, the period until scheduled maturity of the Company’s convertible debt investments was between 2.9 and 5.0 years.

Credit losses on convertible debt investments are measured based on the present value of expected future cash flows compared to amortized cost. Impairment losses are recognized through an allowance and recoveries of previously impaired amounts are recorded as an immediate reversal of all or a portion of the allowance. In addition, the allowance for expected credit losses cannot cause the amortized cost net of the allowance to be below fair value. A progression of the allowance for expected credit losses on convertible debt investments is shown below:


	Year Ended September 30,
	2024		2023
Balance at beginning of year	$	101.3	$	—
Provision for expected credit losses on securities with no previous allowance	—		101.3

Reductions for securities intended to be sold / exchanged	(99.4)		—
Balance at end of year	$	1.9	$	101.3

INCOME TAXES - Components of Deferred Income Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
DEFERRED TAX ASSETS
Lease liabilities	$ 67.6	$ 70.0
Intangible assets	62.2	79.2
Net operating loss carryovers	56.4	67.3
Interest limitation carryforward	55.9	35.9
Convertible debt investments	43.6	33.4
Accrued liabilities	43.2	48.7
Outside basis difference in equity investments	23.1	10.4
Inventories	16.1	26.1
Foreign tax credit carryovers	15.2	16.3
Other	22.4	23.8
Gross deferred tax assets	405.7	411.1
Valuation allowance	(96.5)	(87.7)
Total deferred tax assets	309.2	323.4
DEFERRED TAX LIABILITIES
Lease right-of-use assets	(62.0)	(62.1)
Property, plant and equipment	(58.5)	(62.7)
Other	(4.4)	(9.9)
Total deferred tax liabilities	(124.9)	(134.7)
Net deferred tax asset	$ 184.3	$ 188.7

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Allowance for expected credit losses
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 116.4	$ 14.4	$ 16.8
Additions Other	0.0	0.0	0.0
Additions Charged to Expense	3.7	109.6	5.8
Deductions Credited and Write-Offs	(108.6)	(7.6)	(8.2)
Balance at End of Period	11.5	116.4	14.4
Income tax valuation allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	87.7	40.7	32.3
Additions Other	3.6	9.5	0.0
Additions Charged to Expense	13.7	37.8	9.0
Deductions Credited and Write-Offs	(8.5)	(0.3)	(0.6)
Balance at End of Period	$ 96.5	$ 87.7	$ 40.7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Economic Lives of Assets (Details)	Sep. 30, 2024
Land improvements \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Land improvements \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	25 years
Buildings \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Buildings \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	40 years
Machinery and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	3 years
Machinery and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	15 years
Furniture and fixtures \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	6 years
Furniture and fixtures \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Software \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	3 years
Software \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	8 years

GOODWILL AND INTANGIBLE ASSETS, NET - Rollforward of Carrying Amount of Goodwill by Reportable Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2024
Goodwill [Line Items]
Goodwill	$ 873.0	$ 872.8	$ 873.0
Accumulated impairment losses	(629.1)	(618.8)	(629.1)
Goodwill, net	243.9	254.0	243.9
Foreign currency translation	0.2
Impairment	(10.3)
U.S. Consumer
Goodwill [Line Items]
Goodwill	245.7	245.7	245.7
Accumulated impairment losses	(1.8)	(1.8)	(1.8)
Goodwill, net	243.9	243.9	243.9
Foreign currency translation	0.0
Impairment	0.0
Hawthorne
Goodwill [Line Items]
Goodwill	617.0	617.0	617.0
Accumulated impairment losses	(617.0)	(617.0)	(617.0)
Goodwill, net	0.0	0.0	0.0
Foreign currency translation	0.0
Impairment	0.0	(522.4)
Other
Goodwill [Line Items]
Goodwill	10.3	10.1	10.3
Accumulated impairment losses	(10.3)	0.0	(10.3)
Goodwill, net		$ 10.1	$ 0.0
Foreign currency translation	0.2
Impairment	$ (10.3)

- Definition

Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482598/350-20-45-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

+ Details

ASSOCIATE MEDICAL BENEFITS

12 Months Ended

Sep. 30, 2024

Defined Benefit Plan, Postretirement Medical Plan with Prescription Drug Benefits [Abstract]

ASSOCIATE MEDICAL BENEFITS

The Company provides comprehensive major medical benefits to its associates. The Company is self-insured for certain health benefits up to $1.0 per occurrence per individual. The cost of such benefits is recognized as expense in the period the claim is incurred and was $42.5, $40.1 and $46.6 in fiscal 2024, fiscal 2023 and fiscal 2022, respectively.

The Company also provides comprehensive major medical benefits to certain retired associates and their dependents. Substantially all of the Company’s domestic associates who were hired before January 1, 1998 become eligible for these benefits if they retire at age 55 or older with more than ten years of service. The retiree medical plan requires certain minimum contributions from retired associates and includes provisions to limit the overall cost increases the Company is required to cover. The Company funds its portion of retiree medical benefits as claims are paid.

The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.


	2024		2023

Change in Accumulated Plan Benefit Obligation (“APBO”):
Benefit obligation at beginning of year	$	13.3	$	15.7
Service cost	0.1		0.1
Interest cost	0.8		0.8
Plan participants’ contributions	0.3		0.4
Actuarial (gain) loss	1.5		(2.2)


Benefits paid	(2.2)		(1.5)

Benefit obligation at end of year	$	13.8	$	13.3
Change in plan assets:
Fair value of plan assets at beginning of year	$	—	$	—
Employer contribution	1.9		1.1
Plan participants’ contributions	0.3		0.4
Gross benefits paid	(2.2)		(1.5)
Fair value of plan assets at end of year	$	—	$	—
Unfunded status at end of year	$	(13.8)	$	(13.3)


	2024			2023

Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	$	(1.3)		$	(1.4)
Non-current liabilities	(12.5)			(11.9)
Total amount accrued	$	(13.8)		$	(13.3)
Amounts recognized in accumulated other comprehensive (income) loss consist of:
Actuarial gain	$	(1.3)		$	(3.4)

Total accumulated other comprehensive income	$	(1.3)		$	(3.4)
Total change in other comprehensive income attributable to:
Gain (loss) during the period	$	(1.5)		$	2.2

Reclassification to net earnings	(0.6)			(0.2)
Total change in other comprehensive income	$	(2.1)		$	2.0

Discount rate used in development of APBO	4.86		%	5.98		%

Net periodic benefit cost (income) was $0.3, $0.7 and $(0.2) during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. For measurement as of September 30, 2024, management has assumed that health care costs will increase at an annual rate of 6.50%, and thereafter decrease to an ultimate trend rate of 4.50% in 2033.

The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:


	Gross Benefit Payments		Retiree Contributions		Net Company Payments

2025	$	1.6	$	(0.3)	$	1.3
2026	1.8		(0.4)		1.3
2027	1.9		(0.6)		1.4
2028	2.0		(0.7)		1.3
2029	2.1		(0.7)		1.3
2030 – 2034	9.5		(3.7)		5.7

ACQUISITIONS AND INVESTMENTS - True Liberty Bags (Details) - USD ($) $ in Millions	Dec. 23, 2021	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Business Acquisition [Line Items]
Goodwill		$ 243.9	$ 243.9	$ 254.0
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 0.0	$ 0.0
True Liberty Bags \| Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	$ 10.1
Inventory and accounts receivable acquired	1.1
Finite-lived intangible assets acquired	5.8
Goodwill	$ 3.2
True Liberty Bags \| Hawthorne \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	15 years

- Definition

+ References

+ Details

INCOME TAXES (Tables)

12 Months Ended

Sep. 30, 2024

Income Tax Disclosure [Abstract]

Provision (Benefit) For Income Taxes Allocated to Continuing Operations

The provision (benefit) for income taxes consisted of the following:


	Year Ended September 30,
	2024		2023		2022

Current:
Federal	$	2.4	$	3.7	$	22.8
State	2.5		0.6		9.3
Foreign	(5.3)		1.6		8.7
Total current	(0.4)		5.9		40.8
Deferred:
Federal	11.6		(62.1)		(125.5)
State	(3.8)		(5.2)		(23.3)
Foreign	3.9		(11.8)		(12.6)
Total deferred	11.7		(79.1)		(161.4)
Income tax expense (benefit)	$	11.3	$	(73.2)	$	(120.6)

The Domestic and Foreign Components of Income From Continuing Operations Before Income Taxes

The domestic and foreign components of loss before income taxes were as follows:


	Year Ended September 30,
	2024		2023		2022

Domestic	$	(10.8)	$	(376.2)	$	(427.3)
Foreign	(12.8)		(77.1)		(130.8)
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)

Reconciliation of the Federal Corporate Income Tax Rate and the Effective Tax Rate

A reconciliation of the federal corporate income tax rate and the effective tax rate on loss before income taxes is summarized below:


	Year Ended September 30,
	2024		2023		2022
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.0)		0.2		(1.6)
State taxes, net of federal benefit	8.0		3.2		2.6
Effect of other permanent differences	(32.8)		(0.8)		2.8
Research and Experimentation and other federal tax credits	2.9		0.2		0.2
Effect of tax contingencies	3.7		0.1		(1.8)
Change in valuation allowances	(57.4)		(8.7)		(0.9)
Other	8.7		1.0		(0.7)
Effective income tax rate	(47.9)	%	16.2	%	21.6	%

Components of Deferred Income Tax Assets and Liabilities


	September 30,
	2024		2023

DEFERRED TAX ASSETS
Lease liabilities	$	67.6	$	70.0
Intangible assets	62.2		79.2
Net operating loss carryovers	56.4		67.3
Interest limitation carryforward	55.9		35.9
Convertible debt investments	43.6		33.4
Accrued liabilities	43.2		48.7
Outside basis difference in equity investments	23.1		10.4
Inventories	16.1		26.1
Foreign tax credit carryovers	15.2		16.3

Other	22.4		23.8
Gross deferred tax assets	405.7		411.1
Valuation allowance	(96.5)		(87.7)
Total deferred tax assets	309.2		323.4
DEFERRED TAX LIABILITIES
Lease right-of-use assets	(62.0)		(62.1)
Property, plant and equipment	(58.5)		(62.7)


Other	(4.4)		(9.9)
Total deferred tax liabilities	(124.9)		(134.7)
Net deferred tax asset	$	184.3	$	188.7

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the unrecognized tax benefits is as follows:


	Year Ended September 30,
	2024		2023		2022

Balance at beginning of year	$	34.6	$	35.8	$	24.1
Additions for tax positions of the current year	0.2		0.2		11.3
Additions for tax positions of prior years	0.1		3.8		2.2
Reductions for tax positions of prior years	(3.7)		(0.2)		(2.5)
Settlements with tax authorities	(0.7)		(0.1)		1.3
Expiration of statutes of limitation	(4.8)		(4.9)		(0.6)
Balance at end of year	$	25.7	$	34.6	$	35.8

SEGMENT INFORMATION - Additional Information (Details)	12 Months Ended
SEGMENT INFORMATION - Additional Information (Details)	Sep. 30, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	3

GOODWILL AND INTANGIBLE ASSETS, NET - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Goodwill [Line Items]
Amortization expense	$ 15.7	$ 25.2	$ 37.1
Goodwill	243.9	243.9	254.0
Trade names
Goodwill [Line Items]
Impairment charge		72.0
Customer relationships
Goodwill [Line Items]
Impairment charge		45.7
Hawthorne
Goodwill [Line Items]
Goodwill	0.0	0.0	0.0
U.S. Consumer
Goodwill [Line Items]
Goodwill	243.9	$ 243.9	243.9
Other
Goodwill [Line Items]
Goodwill	$ 0.0		$ 10.1

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

+ Details

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Values of the Company's Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	$ (7.5)	$ 40.2
Designated as Hedging Instruments \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	(3.6)	33.7
Designated as Hedging Instruments \| Interest rate swap agreements \| Other assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.0	14.7
Designated as Hedging Instruments \| Interest rate swap agreements \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.9	16.7
Designated as Hedging Instruments \| Interest rate swap agreements \| Other current liabilities \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	(0.2)	0.0
Designated as Hedging Instruments \| Interest rate swap agreements \| Other liabilities \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	(5.1)	0.0
Designated as Hedging Instruments \| Commodity hedging instruments \| Prepaid and other current assets \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative asset	0.8	2.3
Derivatives not designated as Hedging Instruments \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	(3.9)	6.5
Derivatives not designated as Hedging Instruments \| Commodity hedging instruments \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.0	0.9
Derivatives not designated as Hedging Instruments \| Currency forward contracts \| Prepaid and other current assets \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative asset	0.1	5.6
Derivatives not designated as Hedging Instruments \| Currency forward contracts \| Other current liabilities \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	$ (4.0)	$ 0.0

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on OCI and the Condensed, Consolidated Statements of Operations (Details) - Fair value, inputs, level 2 - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Derivatives not designated as Hedging Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ (11.6)	$ (13.5)
Derivatives not designated as Hedging Instruments \| Currency forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ (9.6)	$ (14.7)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Operating Income (Expense), Net	Other Operating Income (Expense), Net
Derivatives not designated as Hedging Instruments \| Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ (2.0)	$ 1.2
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	$ (7.9)	$ 4.2
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	7.3	17.4
Cash Flow Hedging \| Interest rate swap agreements
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	(7.1)	11.3
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	$ 11.7	$ 11.5
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest expense	Interest expense
Cash Flow Hedging \| Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	$ (0.8)	$ (7.1)
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	$ (4.4)	$ 5.9
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales

INCOME TAXES - Reconciliation of the Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 34.6	$ 35.8	$ 24.1
Additions for tax positions of the current year	0.2	0.2	11.3
Additions for tax positions of prior years	0.1	3.8	2.2
Reductions for tax positions of prior years	(3.7)	(0.2)	(2.5)
Settlements with tax authorities	(0.7)	(0.1)	1.3
Expiration of statutes of limitation	(4.8)	(4.9)	(0.6)
Balance at end of year	$ 25.7	$ 34.6	$ 35.8

LEASES

12 Months Ended

Sep. 30, 2024

Leases [Abstract]

LEASES

The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At September 30, 2024, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $29.6. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the consolidated financial statements for fiscal 2024.

The Company leases certain vehicles (primarily cars and light trucks) under agreements that are cancellable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of September 30, 2024, the Company’s residual value guarantee would have approximated $6.3.

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	September 30, 2024		September 30, 2023

Operating leases:
Right-of-use assets	Other assets	$	265.4	$	262.6

Current lease liabilities	Other current liabilities	75.3		76.4
Non-current lease liabilities	Other liabilities	215.8		220.1
Total operating lease liabilities		$	291.1	$	296.5

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	15.2	$	14.5

Current lease liabilities	Current portion of debt	2.6		1.9
Non-current lease liabilities	Long-term debt	15.2		15.0
Total finance lease liabilities		$	17.8	$	16.9

Components of lease cost were as follows:


	Year Ended September 30,
	2024		2023		2022

Operating lease cost (a)	$	85.8	$	92.3	$	86.7
Variable lease cost	30.3		28.6		35.9


Finance lease cost
Amortization of right-of-use assets	2.6		3.0		6.4
Interest on lease liabilities	0.8		0.8		1.2
Total finance lease cost	$	3.4	$	3.8	$	7.6

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Year Ended September 30,
	2024		2023		2022

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	99.2	$	93.0	$	83.9
Operating cash flows from finance leases	0.8		0.8		1.2
Financing cash flows from finance leases	2.3		2.7		5.9

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	77.0	$	90.4	$	71.9
Finance leases	3.4		—		1.5

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	5.2		5.4
Finance leases	8.1		9.5

Weighted-average discount rate:
Operating leases	5.9	%	5.2	%
Finance leases	4.7	%	4.4	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:


Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

LEASES

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	September 30, 2024		September 30, 2023

Operating leases:
Right-of-use assets	Other assets	$	265.4	$	262.6

Current lease liabilities	Other current liabilities	75.3		76.4
Non-current lease liabilities	Other liabilities	215.8		220.1
Total operating lease liabilities		$	291.1	$	296.5

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	15.2	$	14.5

Current lease liabilities	Current portion of debt	2.6		1.9
Non-current lease liabilities	Long-term debt	15.2		15.0
Total finance lease liabilities		$	17.8	$	16.9

Components of lease cost were as follows:


	Year Ended September 30,
	2024		2023		2022

Operating lease cost (a)	$	85.8	$	92.3	$	86.7
Variable lease cost	30.3		28.6		35.9


Finance lease cost
Amortization of right-of-use assets	2.6		3.0		6.4
Interest on lease liabilities	0.8		0.8		1.2
Total finance lease cost	$	3.4	$	3.8	$	7.6

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Year Ended September 30,
	2024		2023		2022

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	99.2	$	93.0	$	83.9
Operating cash flows from finance leases	0.8		0.8		1.2
Financing cash flows from finance leases	2.3		2.7		5.9

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	77.0	$	90.4	$	71.9
Finance leases	3.4		—		1.5

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	5.2		5.4
Finance leases	8.1		9.5

Weighted-average discount rate:
Operating leases	5.9	%	5.2	%
Finance leases	4.7	%	4.4	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2024 were as follows:


Year	Operating Leases		Finance Leases
2025	$	89.8	$	3.4
2026	73.5		3.0
2027	49.2		2.6
2028	38.8		2.2
2029	27.1		1.7
Thereafter	62.5		8.6
Total lease payments	340.9		21.5
Less: Imputed interest	(49.8)		(3.7)
Total lease liabilities	$	291.1	$	17.8

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS - Summary of Balance Sheet Accounts (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
INVENTORIES:
Finished goods	$ 246.6	$ 506.2
Raw materials	256.8	272.5
Work-in-progress	84.1	101.6
Inventories	587.5	880.3
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	1,414.9	1,375.7
Less: accumulated depreciation	(805.4)	(765.4)
Property, plant and equipment, net	609.5	610.3
OTHER ASSETS:
Operating lease right-of-use assets	265.4	262.6
Net deferred tax assets	191.3	189.8
Convertible debt investments	45.8	85.8
Accrued pension, postretirement and executive retirement assets	62.7	64.1
Other	8.9	30.8
Other assets	574.1	633.1
OTHER CURRENT LIABILITIES:
Current lease liabilities	75.3	76.4
Advertising and promotional accruals	131.2	143.0
Payroll and other compensation accruals	72.0	51.2
Accrued taxes	16.7	28.5
Accrued interest	29.4	31.9
Other	118.4	119.2
Other current liabilities	443.0	450.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	215.8	220.1
Accrued pension, postretirement and executive retirement liabilities	73.0	76.7
Net deferred tax liabilities	7.0	1.1
Other	42.2	52.0
Other non-current liabilities	338.0	349.9
Machinery and equipment
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	683.6	651.7
Buildings
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	305.8	277.1
Land and improvements
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	152.9	149.0
Construction in progress
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	78.7	104.6
Software
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	107.2	109.9
Furniture and fixtures
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	62.6	62.3
Finance leases
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	$ 24.1	$ 21.1

MARKETING AGREEMENT - Additional Information (Details)	Aug. 01, 2019 USD ($)
Restated Marketing Agreement
Schedule of Costs Related to Purchase Obligations [Line Items]
Commission threshold, percentage of program earnings	50.00%
Annual contribution payment	$ 18,000,000.0
Third Restated Agreement
Schedule of Costs Related to Purchase Obligations [Line Items]
Minimum EBIT to avoid reduction of contribution payment	36,000,000.0
Minimum EBIT	50,000,000.0
Minimum termination fee payable	175,000,000.0
Brand decommissioning event payable	$ 375,000,000.0
Minimum termination fee payable, multiple of average program earnings, prior 3 years	4
Minimum termination fee payable, threshold	$ 186,400,000

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

12 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Outstanding Commodity Contracts that Hedge Forecasted Purchases

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:


	September 30,
	2024	2023
Commodity
Urea	51,000 tons	52,500 tons

Diesel	1,092,000 gallons	1,974,000 gallons

Heating Oil	42,000 gallons	966,000 gallons

Summary of Fair Values of the Company's Derivative Instruments

The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows:


		Assets / (Liabilities)
		2024		2023
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value
Interest rate swap agreements	Prepaid and other current assets	$	0.9	$	16.7
	Other assets	—		14.7
	Other current liabilities	(0.2)		—
	Other liabilities	(5.1)		—
Commodity hedging instruments	Prepaid and other current assets	0.8		2.3

Total derivatives designated as hedging instruments		$	(3.6)	$	33.7

Derivatives Not Designated as Hedging Instruments	Balance Sheet Location
Currency forward contracts	Prepaid and other current assets	$	0.1	$	5.6
	Other current liabilities	(4.0)		—
Commodity hedging instruments	Prepaid and other current assets	—		0.9

Total derivatives not designated as hedging instruments		(3.9)		6.5
Total derivatives		$	(7.5)	$	40.2

Schedule of the Effect of Derivative Instruments on AOCI and Operations

The effect of derivative instruments on AOCL, net of tax, and the Consolidated Statements of Operations for the years ended September 30 was as follows:


	Amount of Gain / (Loss) Recognized in AOCL
Derivatives in Cash Flow Hedging Relationships	2024		2023

Interest rate swap agreements	$	(7.1)	$	11.3
Commodity hedging instruments	(0.8)		(7.1)
Total	$	(7.9)	$	4.2


	Reclassified from AOCL into	Amount of Gain / (Loss)
Derivatives in Cash Flow Hedging Relationships	Statement of Operations	2024		2023

Interest rate swap agreements	Interest expense	$	11.7	$	11.5
Commodity hedging instruments	Cost of sales	(4.4)		5.9
Total		$	7.3	$	17.4


	Recognized in	Amount of Gain / (Loss)
Derivatives Not Designated as Hedging Instruments	Statement of Operations	2024		2023

Currency forward contracts	Other income / expense, net	$	(9.6)	$	(14.7)
Commodity hedging instruments	Cost of sales	(2.0)		1.2
Total		$	(11.6)	$	(13.5)

FAIR VALUE MEASUREMENTS - Changes in Allowance For Expected Credit Losses on Convertible Debt Instruments (Details) - Convertible debt investments - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	$ 101.3	$ 0.0
Provision for expected credit losses on securities with no previous allowance	0.0	101.3
Reductions for securities intended to be sold / exchanged	(99.4)	0.0
Balance at end of year	$ 1.9	$ 101.3

EQUITY - Additional Information (Details) - Miracle-Gro	Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ownership of outstanding common shares (percent)	24.00%
Condition for ownership of voting stock (percent)	49.00%
Tender offer for ownership of voting power (as a percent)	100.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Condition for ownership of voting stock (percent)	50.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

COMMITMENTS (Details) $ in Millions	Sep. 30, 2024 USD ($)
Unrecorded Unconditional Purchase Obligation, Fiscal Year Maturity [Abstract]
2025	$ 310.9
2026	193.5
2027	79.2
2028	39.3
2029	24.6
Thereafter	33.7
Unrecognized unconditional purchase obligations due	$ 681.2

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES
Net income (loss)	$ (34.9)	$ (380.1)	$ (437.5)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Impairment, restructuring and other	84.3	288.6	666.8
Share-based compensation expense	80.4	68.9	34.3
Depreciation	64.9	67.3	68.1
Amortization	15.7	25.2	37.1
Deferred taxes	9.3	(58.7)	(182.8)
Equity in loss of unconsolidated affiliates	68.1	101.1	12.9
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	128.2	77.7	102.8
Inventories	293.8	450.5	(203.8)
Prepaid and other current assets	10.2	18.6	(3.3)
Accounts payable	(1.6)	(153.6)	(171.2)
Other current liabilities	(45.4)	52.0	(68.4)
Other non-current items	(6.2)	(30.7)	20.1
Other, net	0.7	4.2	(4.1)
Net cash provided by (used in) operating activities	667.5	531.0	(129.0)
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets	2.4	2.5	63.3
Investments in property, plant and equipment	(84.0)	(92.8)	(113.5)
Proceeds from loans receivable	0.0	37.0	0.0
Investments in unconsolidated affiliates	(21.4)	0.0	0.0
Payment for acquisitions, net of cash acquired	0.0	0.0	(237.3)
Purchase of convertible debt investments	0.0	0.0	(25.0)
Other investing, net	2.6	(12.4)	29.3
Net cash used in investing activities	(100.4)	(65.7)	(283.2)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	648.5	1,336.2	3,617.4
Repayments under revolving and bank lines of credit and term loans	(1,039.5)	(1,689.8)	(2,937.3)
Financing and issuance fees	0.0	(6.4)	(9.6)
Dividends paid	(151.3)	(149.1)	(166.2)
Purchase of Common Shares	(5.1)	(9.3)	(257.9)
Cash received from exercise of stock options	3.8	2.3	3.3
Other financing, net	15.7	(4.0)	5.6
Net cash (used in) provided by financing activities	(527.9)	(520.1)	255.3
Effect of exchange rate changes on cash	0.5	(0.1)	(0.4)
Net increase (decrease) in cash and cash equivalents	39.7	(54.9)	(157.3)
Cash and cash equivalents at beginning of year	31.9	86.8	244.1
Cash and cash equivalents at end of year	$ 71.6	$ 31.9	$ 86.8

DEBT - Receivables Facility (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Apr. 07, 2017
Debt Instrument [Line Items]
Borrowings or receivables pledged as collateral	$ 2,242.8	$ 2,630.6
Amendments
Debt Instrument [Line Items]
Maximum aggregate amount			$ 400.0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

+ Details

- Definition

Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-13

Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481962/310-10-50-7A

Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481962/310-10-50-29

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name Regulation S-K (SK)
-Number 229
-Section 1405
-Paragraph a
-Subparagraph (1)
-Publisher SEC

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name Regulation S-K (SK)
-Number 229
-Section 1405
-Paragraph a
-Subparagraph (2)
-Publisher SEC

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1404
-Paragraph a
-Publisher SEC

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 80
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-80

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 79
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-79

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479344/326-20-45-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479319/326-20-50-14

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479319/326-20-50-5

+ Details

ASSOCIATE MEDICAL BENEFITS (Tables)

12 Months Ended

Sep. 30, 2024

Defined Benefit Plan, Postretirement Medical Plan with Prescription Drug Benefits [Abstract]

Schedule of Changes in Accumulated Postemployment Benefit Obligations

The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.


	2024		2023

Change in Accumulated Plan Benefit Obligation (“APBO”):
Benefit obligation at beginning of year	$	13.3	$	15.7
Service cost	0.1		0.1
Interest cost	0.8		0.8
Plan participants’ contributions	0.3		0.4
Actuarial (gain) loss	1.5		(2.2)


Benefits paid	(2.2)		(1.5)

Benefit obligation at end of year	$	13.8	$	13.3
Change in plan assets:
Fair value of plan assets at beginning of year	$	—	$	—
Employer contribution	1.9		1.1
Plan participants’ contributions	0.3		0.4
Gross benefits paid	(2.2)		(1.5)
Fair value of plan assets at end of year	$	—	$	—
Unfunded status at end of year	$	(13.8)	$	(13.3)


	2024			2023

Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	$	(1.3)		$	(1.4)
Non-current liabilities	(12.5)			(11.9)
Total amount accrued	$	(13.8)		$	(13.3)
Amounts recognized in accumulated other comprehensive (income) loss consist of:
Actuarial gain	$	(1.3)		$	(3.4)

Total accumulated other comprehensive income	$	(1.3)		$	(3.4)
Total change in other comprehensive income attributable to:
Gain (loss) during the period	$	(1.5)		$	2.2

Reclassification to net earnings	(0.6)			(0.2)
Total change in other comprehensive income	$	(2.1)		$	2.0

Discount rate used in development of APBO	4.86		%	5.98		%

Schedule of Expected Benefit Payments

The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:


	Gross Benefit Payments		Retiree Contributions		Net Company Payments

2025	$	1.6	$	(0.3)	$	1.3
2026	1.8		(0.4)		1.3
2027	1.9		(0.6)		1.4
2028	2.0		(0.7)		1.3
2029	2.1		(0.7)		1.3
2030 – 2034	9.5		(3.7)		5.7

INCOME TAXES - Reconciliation of The Federal Corporate Income Tax Rate and The Effective Tax Rate (Details)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Statutory income tax rate	21.00%	21.00%	21.00%
Effect of foreign operations	(2.00%)	0.20%	(1.60%)
State taxes, net of federal benefit	8.00%	3.20%	2.60%
Effect of other permanent differences	(32.80%)	(0.80%)	2.80%
Research and Experimentation and other federal tax credits	2.90%	0.20%	0.20%
Effect of tax contingencies	3.70%	0.10%	(1.80%)
Change in valuation allowances	(57.40%)	(8.70%)	(0.90%)
Other	8.70%	1.00%	(0.70%)
Effective income tax rate	(47.90%)	16.20%	21.60%

GOODWILL AND INTANGIBLE ASSETS, NET - Schedule of Amortization Expense (Details) $ in Millions	Sep. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 12.6
2026	11.5
2027	10.7
2028	9.1
2029	$ 6.9

MARKETING AGREEMENT (Tables)

12 Months Ended

Sep. 30, 2024

Marketing Agreement [Abstract]

Marketing Agreement

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Consolidated Statements of Operations are as follows:


	Year Ended September 30
	2024		2023		2022

Gross commission	$	90.8	$	75.7	$	83.4
Contribution expenses	(18.0)		(18.0)		(18.0)

Net commission	72.8		57.7		65.4
Reimbursements associated with Roundup® marketing agreement	91.2		82.5		67.9
Total net sales associated with Roundup® marketing agreement	$	164.0	$	140.2	$	133.3

EQUITY - Schedule of Aggregate Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
No. of Options
Granted (in shares)	1,356,698
Exercised (in shares)	(35,027)
Wtd. Avg. Exercise Price
Granted (in USD per share)	$ 53.75
Exercised (USD per share)	$ 58.52
Aggregate intrinsic value, exercisable	$ 8.9
Options
No. of Options
Beginning balance (shares)	1,191,183
Forfeited (shares)	(135,182)
Ending balance (shares)	2,377,672	1,191,183
Exercisable (shares)	493,832
Wtd. Avg. Exercise Price
Beginning balance (USD per share)	$ 76.64
Forfeited (in USD per share)	55.69
Ending balance (USD per share)	65.03	$ 76.64
Exercisable (USD per share)	$ 108.97
Wtd. Avg. Remaining Life (in years)	7 years 6 months	6 years 7 months 6 days
Wtd. Avg. Remaining Life, Exercisable	2 years 7 months 6 days
Aggregate intrinsic value for awards outstanding	$ 71.4

EQUITY - Share Repurchases (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Feb. 06, 2020
Accelerated Share Repurchases [Line Items]
Number of common shares repurchased (in shares)			1.1
Value of common shares repurchased to be held in treasury			$ 175.0
Tax withholding	$ 5.1	$ 9.3	$ 82.9
February 6, 2020 Program
Accelerated Share Repurchases [Line Items]
Stock repurchase authorization				$ 750.0

- Definition

Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.

+ References + Details

- Definition

Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.

+ References + Details

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Sep. 30, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

FAIR VALUE MEASUREMENTS - Changes in Level 3 Convertible Debt Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ (53.2)	$ (24.8)	$ (96.4)
Net Unrealized Loss On Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Other comprehensive income (loss) before reclassifications	(40.4)	(34.9)	(102.0)
Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized gains (losses) included in net earnings	(64.2)	(97.6)
Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments \| Net Unrealized Loss On Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Other comprehensive income (loss) before reclassifications	24.2	66.4
Fair value, inputs, level 3 \| Estimate of Fair Value Measurement \| Fair Value, Measurements, Recurring \| Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of year	85.8	117.0
Fair value at end of year	$ 45.8	$ 85.8	$ 117.0

- Definition

Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 103
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-103

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481830/320-10-45-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479130/326-30-45-1

+ Details

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Derivatives not designated as Hedging Instruments \| Currency forward contracts
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount	$ 148.4	$ 123.1
Designated as Hedging Instruments \| Interest rate swap agreements
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount	450.0	$ 600.0
Interest rate gain amount expected to be reclassified to earnings during the next 12 months	4.7
Designated as Hedging Instruments \| Commodity hedging instruments
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Commodity gain amount expected to be reclassified to earnings during the next 12 months	$ 0.7

LEASES - (Weighted-Average Remaining Lease Term and Discount Rate Schedule) (Details)	Sep. 30, 2024	Sep. 30, 2023
Leases [Abstract]
Operating leases, weighted average remaining term (in years)	5 years 2 months 12 days	5 years 4 months 24 days
Finance leases, weighted average remaining term (in years)	8 years 1 month 6 days	9 years 6 months
Operating leases, weighted average discount rate (percent)	5.90%	5.20%
Finance leases, weighted average discount rate (percent)	4.70%	4.40%

FAIR VALUE MEASUREMENTS - Summary of Fair Value of Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Senior Notes \| Senior Notes due 2031 – 4.000%
Liabilities
Interest rate (percent)	4.00%	4.00%			4.00%
Senior Notes \| Senior Notes due 2032 – 4.375%
Liabilities
Interest rate (percent)	4.375%	4.375%		4.375%
Senior Notes \| Senior Notes - 4.500%
Liabilities
Interest rate (percent)	4.50%	4.50%				4.50%
Senior Notes \| Senior Notes due 2026 – 5.250%
Liabilities
Interest rate (percent)	5.25%	5.25%					5.25%
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2031 – 4.000%
Liabilities
Long-term debt	$ 500.0	$ 500.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2032 – 4.375%
Liabilities
Long-term debt	400.0	400.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes - 4.500%
Liabilities
Long-term debt	450.0	450.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2026 – 5.250%
Liabilities
Long-term debt	250.0	250.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Revolving loans
Liabilities
Long-term debt	0.0	88.3
Reported Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Term loans
Liabilities
Long-term debt	625.0	925.0
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2031 – 4.000%
Liabilities
Long-term debt	456.3	380.0
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2032 – 4.375%
Liabilities
Long-term debt	370.0	304.0
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes - 4.500%
Liabilities
Long-term debt	432.0	366.8
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2026 – 5.250%
Liabilities
Long-term debt	248.8	233.1
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Revolving loans
Liabilities
Long-term debt	0.0	88.3
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Term loans
Liabilities
Long-term debt	625.0	925.0
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 1
Assets
Cash equivalents	51.2	1.2
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 1 \| Investment securities in non-qualified retirement plan assets
Assets
Other	32.4	36.3
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 2 \| Other Long-term Debt
Liabilities
Long-term debt	0.0	0.4
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 3 \| Convertible debt investments
Assets
Convertible debt investments	45.8	85.8
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 1
Assets
Cash equivalents	51.2	1.2
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 1 \| Investment securities in non-qualified retirement plan assets
Assets
Other	32.4	36.3
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Other Long-term Debt
Liabilities
Long-term debt	0.0	0.4
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 3 \| Convertible debt investments
Assets
Convertible debt investments	$ 45.8	$ 85.8	$ 117.0

EARNINGS PER COMMON SHARE (Tables)

12 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Information to Calculate Basic and Diluted Earnings (Loss) Per Common Share

The following table presents information necessary to calculate basic and diluted net loss per Common Share for the periods indicated:


	Year Ended September 30,
	2024		2023		2022





Net loss	$	(34.9)	$	(380.1)	$	(437.5)
Basic net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5


Basic net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)
Diluted net loss per common share:
Weighted-average common shares outstanding during the period	56.8		56.0		55.5
Dilutive potential common shares	—		—		—
Weighted-average number of common shares outstanding and dilutive potential common shares	56.8		56.0		55.5


Diluted net loss per common share	$	(0.61)	$	(6.79)	$	(7.88)

Antidilutive stock options outstanding	0.4		0.4		0.2

SEGMENT INFORMATION (Tables)

12 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Segment Financial Information

The following tables present financial information for the Company’s reportable segments for the periods indicated:


	Year Ended September 30,
	2024		2023		2022

Net Sales:
U.S. Consumer	$	3,013.7	$	2,843.7	$	2,928.8
Hawthorne	294.7		467.3		716.2
Other	244.3		240.3		279.1
Consolidated	$	3,552.7	$	3,551.3	$	3,924.1
Segment Profit (Loss):
U.S. Consumer	$	498.0	$	454.1	$	568.6
Hawthorne	(14.2)		(48.1)		(21.1)
Other	4.7		12.4		20.2
Total Segment Profit	488.5		418.4		567.7
Corporate	(117.7)		(101.6)		(112.4)
Intangible asset amortization	(15.7)		(25.2)		(37.1)

Impairment, restructuring and other	(146.3)		(466.0)		(852.2)
Equity in loss of unconsolidated affiliates	(68.1)		(101.1)		(12.9)

Interest expense	(158.8)		(178.1)		(118.1)
Other non-operating income (expense), net	(5.5)		0.3		6.9
Loss before income taxes	$	(23.6)	$	(453.3)	$	(558.1)
Depreciation and amortization:
U.S. Consumer	$	56.2	$	58.2	$	55.8
Hawthorne	16.7		25.8		34.8
Other	5.9		5.6		7.0
Corporate	1.8		2.9		7.6
	$	80.6	$	92.5	$	105.2
Capital expenditures:
U.S. Consumer	$	81.5	$	79.6	$	97.4
Hawthorne	—		8.5		12.4
Other	2.5		4.7		3.7
	$	84.0	$	92.8	$	113.5


	September 30,
	2024		2023

Total assets:
U.S. Consumer	$	2,022.7	$	2,296.2
Hawthorne	387.3		581.6
Other	189.3		189.8
Corporate	272.6		346.1

Consolidated	$	2,871.9	$	3,413.7

Net sales by product category

The following table presents net sales by product category for the periods indicated:


	Year Ended September 30,
	2024		2023		2022

U.S. Consumer:
Growing media and mulch	$	1,310.6	$	1,223.7	$	1,192.6
Lawn care	929.6		897.4		973.6
Controls	414.6		362.9		382.2
Roundup® marketing agreement	162.4		138.7		132.3
Other, primarily gardening	196.5		221.0		248.1
Hawthorne:
Lighting	108.2		165.9		200.0
Nutrients	87.2		105.3		148.0
Growing media	37.3		67.5		119.0
Growing environment	27.7		72.5		143.7
Other, primarily hardware	34.3		56.1		105.5
Other:
Growing media	91.3		93.0		96.6
Lawn care	80.2		75.8		92.9
Other, primarily gardening and controls	72.8		71.5		89.6
Total net sales	$	3,552.7	$	3,551.3	$	3,924.1

Percentages of Largest Customers Consolidated Net Sales

The Company’s two largest customers accounted for the following percentages of net sales for the fiscal years ended September 30:


	Percentage of Net Sales
	2024		2023		2022
The Home Depot	30	%	29	%	28	%
Lowe’s	18	%	18	%	15	%

Net Sales and Long-lived Assets by Geographic Area

The following table presents net sales by geographic area for the periods indicated:


	Year Ended September 30,
	2024		2023		2022

Net sales:
United States	$	3,247.8	$	3,209.5	$	3,554.6
International	304.9		341.8		369.5
	$	3,552.7	$	3,551.3	$	3,924.1

The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area:


	September 30,
	2024		2023

Long-lived assets:
United States	$	630.5	$	644.4
International	73.9		78.7
	$	704.4	$	723.1

EQUITY - Performance-Based Award Activity (Details) - Performance-Based Units - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
No. of Units
Beginning Balance (in shares)	544,790
Granted (in shares)	240,677
Vested (in shares)	(181,791)
Forfeited (in shares)	(194,246)
Ending Balance (in shares)	409,430	544,790
Wtd. Avg. Grant Date Fair Value per Unit
Beginning Balance (USD per share)	$ 76.85
Granted (USD per share)	74.57	$ 66.00	$ 132.74
Vested (USD per share)	59.88
Forfeited (USD per share)	65.89
Ending Balance (USD per share)	$ 86.61	$ 76.85
Shares vested (as a percentage of shares granted)	100.00%

GOODWILL AND INTANGIBLE ASSETS, NET

12 Months Ended

Sep. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS, NET

The following table displays a rollforward of the carrying amount of goodwill by reportable segment:


	U.S. Consumer		Hawthorne		Other		Total
Goodwill	$	245.7	$	617.0	$	10.1	$	872.8
Accumulated impairment losses	(1.8)		(617.0)		—		(618.8)
Balance at September 30, 2022	243.9		—		10.1		254.0

Foreign currency translation	—		—		0.2		0.2

Impairment	—		—		(10.3)		(10.3)

Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2023	243.9		—		—		243.9






Goodwill	245.7		617.0		10.3		873.0
Accumulated impairment losses	(1.8)		(617.0)		(10.3)		(629.1)
Balance at September 30, 2024	$	243.9	$	—	$	—	$	243.9

The following table presents intangible assets, net of accumulated amortization and impairment charges:


	September 30, 2024						September 30, 2023
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount

Finite-lived intangible assets:
Trade names	$	325.8	$	(272.8)	$	53.0	$	322.4	$	(260.7)	$	61.7
Customer relationships	253.1		(223.9)		29.2		251.5		(216.1)		35.4
Technology	50.2		(45.5)		4.7		50.1		(44.5)		5.6
Other	35.0		(27.0)		8.0		34.9		(24.8)		10.1
Total finite-lived intangible assets, net					94.9						112.8
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7

Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	418.8					$	436.7

During fiscal 2023, the Company identified circumstances that indicated the carrying amounts of Hawthorne’s long-lived assets, including trade names and customer relationships, may not be recoverable. Accordingly, the Company performed a recoverability test for long-lived assets during the fourth quarter of fiscal 2023. The Company concluded that the carrying value of these long-lived assets exceeded their estimated fair value and recorded non-cash, pre-tax impairment charges of $72.0 related to trade names and $45.7 related to customer relationships during the fourth quarter of fiscal 2023 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The fair values of long-lived assets were determined using income-based approaches, including the relief-from-royalty method for trade names, that include market participant expectations of cash flows that the assets will generate over the remaining useful life discounted to present value using an appropriate discount rate. These fair value estimates utilize significant unobservable inputs and thus represent Level 3 fair value measurements.

The Company performed annual goodwill impairment testing as of the first day of its fourth quarter of fiscal 2023. This test resulted in a non-cash, pre-tax goodwill impairment charge of $10.3 related to the Other segment, which was recorded during the fourth quarter of fiscal 2023 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The carrying value of goodwill of the Other segment reporting unit after recognizing the impairment is zero. The estimated fair value of the Other segment reporting unit was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to the operating performance of the reporting unit. The fair value estimate utilizes significant unobservable inputs and thus represents a Level 3 fair value measurement.

Total amortization expense was $15.7, $25.2 and $37.1 for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Amortization expense is estimated to be as follows for the years ending September 30:


2025	$	12.6
2026	11.5
2027	10.7
2028	9.1
2029	6.9

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Commodity Contracts that Hedge Forecasted Purchases (Details)	12 Months Ended
	Sep. 30, 2024 T gal	Sep. 30, 2023 T gal
Urea
Derivative [Line Items]
Outstanding commodity contracts, mass \| T	51,000	52,500
Diesel
Derivative [Line Items]
Outstanding commodity contracts, volume	1,092,000	1,974,000
Heating Oil
Derivative [Line Items]
Outstanding commodity contracts, volume	42,000	966,000

ACQUISITIONS AND INVESTMENTS - Luxx Lighting (Details) - USD ($) shares in Millions, $ in Millions	Dec. 30, 2021	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Business Acquisition [Line Items]
Goodwill		$ 243.9	$ 243.9	$ 254.0
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 0.0	$ 0.0
Luxx Lighting, Inc. \| Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	$ 213.2
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	0.1
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	$ 21.0
Inventory and accounts receivable acquired	32.8
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	5.7
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	(24.2)
Finite-lived intangible assets acquired	47.3
Goodwill	$ 151.6
Luxx Lighting, Inc. \| Hawthorne \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Luxx Lighting, Inc. \| Hawthorne \| Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	25 years

ACQUISITIONS AND INVESTMENTS	12 Months Ended
ACQUISITIONS AND INVESTMENTS	Sep. 30, 2024
Business Combinations [Abstract]
ACQUISITIONS AND INVESTMENTS	ACQUISITIONS AND INVESTMENTS CYCO On April 28, 2022, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of S.J. Enterprises PTY LTD, d.b.a. CYCO (“CYCO”), an Australia-based provider of premium nutrients, additives and growing media products for indoor growing sold mostly in the United States, for an estimated purchase price of $37.3. The purchase price includes contingent consideration, a non-cash investing activity, with an initial fair value of $3.1 and a maximum payout of $10.0, which is based on the achievement of certain performance metrics through December 31, 2024 and is not expected to be paid. Prior to the transaction, the Company served as the exclusive distributor of CYCO’s products in the United States. The valuation of the acquired assets included (i) $1.3 of inventory, (ii) $10.5 of finite-lived identifiable intangible assets and (iii) $25.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with initial useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Luxx Lighting On December 30, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of Luxx Lighting, Inc., a provider of lighting products for indoor growing. The purchase price was $213.2, a portion of which was paid by the issuance of 0.1 million Common Shares, a non-cash investing and financing activity, with a fair value of $21.0 based on the share price at the time of payment. The valuation of the acquired assets included (i) $32.8 of inventory and accounts receivable, (ii) $5.7 of other current assets, (iii) $24.2 of current liabilities, (iv) $47.3 of finite-lived identifiable intangible assets and (v) $151.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with initial useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. During the fourth quarter of fiscal 2022, the Company decided it would discontinue and exit the market for certain Hawthorne lighting products and brands, including Luxx Lighting, Inc. Refer to “NOTE 3. IMPAIRMENT, RESTRUCTURING AND OTHER” for more information. True Liberty Bags On December 23, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of True Liberty Bags, a leading provider of liners and storage solutions to dry and cure plant products, for $10.1. The valuation of the acquired assets included (i) $1.1 of inventory, (ii) $5.8 of finite-lived identifiable intangible assets and (iii) $3.2 of tax-deductible goodwill. Identifiable intangible assets included trade names and customer relationships with initial useful lives of 15 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

12 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

The following presents detail regarding certain financial statement accounts:


	September 30,
	2024		2023

INVENTORIES:
Raw materials	$	256.8	$	272.5
Finished goods	246.6		506.2
Work-in-progress	84.1		101.6
	$	587.5	$	880.3
PROPERTY, PLANT AND EQUIPMENT, NET:
Machinery and equipment	$	683.6	$	651.7
Buildings	305.8		277.1
Land and improvements	152.9		149.0
Software	107.2		109.9
Construction in progress	78.7		104.6
Furniture and fixtures	62.6		62.3
Finance leases	24.1		21.1

	1,414.9		1,375.7
Less: accumulated depreciation	(805.4)		(765.4)
	$	609.5	$	610.3
OTHER ASSETS:
Operating lease right-of-use assets	$	265.4	$	262.6
Net deferred tax assets	191.3		189.8
Accrued pension, postretirement and executive retirement assets	62.7		64.1
Convertible debt investments	45.8		85.8


Other	8.9		30.8
	$	574.1	$	633.1


	September 30,
	2024		2023

OTHER CURRENT LIABILITIES:
Advertising and promotional accruals	$	131.2	$	143.0
Current operating lease liabilities	75.3		76.4
Payroll and other compensation accruals	72.0		51.2

Accrued interest	29.4		31.9
Accrued taxes	16.7		28.5



Other	118.4		119.2
	$	443.0	$	450.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	$	215.8	$	220.1
Accrued pension, postretirement and executive retirement liabilities	73.0		76.7
Net deferred tax liabilities	7.0		1.1

Other	42.2		52.0
	$	338.0	$	349.9

IMPAIRMENT, RESTRUCTURING AND OTHER (Tables)

12 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

Schedule of Impairment, Restructuring, and Other Charges

The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:


	Year Ended September 30,
	2024		2023		2022

Cost of sales—impairment, restructuring and other:
Restructuring and other charges, net	$	72.9	$	148.5	$	143.6
Property, plant and equipment impairments	5.3		11.4		16.6
Right-of-use asset impairments	5.3		25.8		—

Operating expenses—impairment, restructuring and other:
Convertible debt other-than-temporary impairments	64.6		101.3		—
Goodwill and intangible asset impairments	2.5		127.9		668.3
Restructuring and other charges (recoveries), net	(4.3)		51.2		40.9
Gains on sale of property, plant and equipment	—		—		(16.2)


Total impairment, restructuring and other charges	$	146.3	$	466.1	$	853.2

Schedule of Reserve

The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:


	Year Ended September 30,
	2024		2023		2022

Amounts accrued at beginning of year	$	40.5	$	31.5	$	1.9
Restructuring charges	11.8		55.6		47.1

Payments	(33.4)		(46.6)		(17.5)
Amounts accrued at end of year	$	18.9	$	40.5	$	31.5

DEBT (Tables)

12 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Schedule of Components of Long-Term Debt

The components of debt are as follows:


	September 30,
	2024		2023

Credit Facilities:
Revolving loans	$	—	$	88.3
Term loans	625.0		925.0
Senior Notes due 2031 – 4.000%	500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0


Finance lease obligations	17.8		16.9
Other	—		0.4
Total debt	2,242.8		2,630.6
Less current portions	52.6		52.3
Less unamortized debt issuance costs	16.0		20.9
Long-term debt	$	2,174.2	$	2,557.4

Schedule of Company's Debt Maturities

The Company’s aggregate scheduled maturities of debt by fiscal year, excluding finance lease obligations, are as follows:


2025	$	50.0
2026	50.0
2027	775.0
2028	—
2029	—
Thereafter	1,350.0
	$	2,225.0

Schedule of Derivative Instruments


Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate




150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References + Details

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

12 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

Exchange Rate Risk Management

The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. The notional amount of outstanding currency forward contracts was $148.4 and $123.1 at September 30, 2024 and 2023, respectively. Contracts outstanding at September 30, 2024 will mature over the next fiscal quarter.

Interest Rate Risk Management

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Swap agreements that were hedging interest payments as of September 30, 2024 and 2023 had a maximum total U.S. dollar equivalent notional amount of $450.0 and $600.0, respectively. Refer to “NOTE 11. DEBT” for the terms of the swap agreements outstanding at September 30, 2024. Included in the AOCL balance at September 30, 2024 was a gain of $4.7 related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

Commodity Price Risk Management

The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea and diesel requirements. Commodity contracts are valued using observable commodity exchange prices in active markets. Included in the AOCL balance at September 30, 2024 was a gain of $0.7 related to commodity hedges that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:


	September 30,
	2024	2023
Commodity
Urea	51,000 tons	52,500 tons

Diesel	1,092,000 gallons	1,974,000 gallons

Heating Oil	42,000 gallons	966,000 gallons

Fair Values of Derivative Instruments

The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows:


		Assets / (Liabilities)
		2024		2023
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value
Interest rate swap agreements	Prepaid and other current assets	$	0.9	$	16.7
	Other assets	—		14.7
	Other current liabilities	(0.2)		—
	Other liabilities	(5.1)		—
Commodity hedging instruments	Prepaid and other current assets	0.8		2.3

Total derivatives designated as hedging instruments		$	(3.6)	$	33.7

Derivatives Not Designated as Hedging Instruments	Balance Sheet Location
Currency forward contracts	Prepaid and other current assets	$	0.1	$	5.6
	Other current liabilities	(4.0)		—
Commodity hedging instruments	Prepaid and other current assets	—		0.9

Total derivatives not designated as hedging instruments		(3.9)		6.5
Total derivatives		$	(7.5)	$	40.2

The effect of derivative instruments on AOCL, net of tax, and the Consolidated Statements of Operations for the years ended September 30 was as follows:


	Amount of Gain / (Loss) Recognized in AOCL
Derivatives in Cash Flow Hedging Relationships	2024		2023

Interest rate swap agreements	$	(7.1)	$	11.3
Commodity hedging instruments	(0.8)		(7.1)
Total	$	(7.9)	$	4.2


	Reclassified from AOCL into	Amount of Gain / (Loss)
Derivatives in Cash Flow Hedging Relationships	Statement of Operations	2024		2023

Interest rate swap agreements	Interest expense	$	11.7	$	11.5
Commodity hedging instruments	Cost of sales	(4.4)		5.9
Total		$	7.3	$	17.4


	Recognized in	Amount of Gain / (Loss)
Derivatives Not Designated as Hedging Instruments	Statement of Operations	2024		2023

Currency forward contracts	Other income / expense, net	$	(9.6)	$	(14.7)
Commodity hedging instruments	Cost of sales	(2.0)		1.2
Total		$	(11.6)	$	(13.5)

DEBT - Company's Debt Maturing in Next Fiscal Years (Details) $ in Millions	Sep. 30, 2024 USD ($)
Debt Disclosure [Abstract]
2025	$ 50.0
2026	50.0
2027	775.0
2028	0.0
2029	0.0
Thereafter	1,350.0
Total debt	$ 2,225.0

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

LEASES - Narrative (Details) $ in Millions	Sep. 30, 2024 USD ($)
Lessee, Lease, Description [Line Items]
Total expected lease liability	$ 681.2
Residual value of leased asset	6.3
Operating Lease, Lease Not yet Commenced
Lessee, Lease, Description [Line Items]
Total expected lease liability	$ 29.6

EQUITY - Restricted Share-Based Awards, Additional Information (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Weighted average grant date fair value (in USD per share)	$ 55.12	$ 59.48	$ 109.10
Compensation costs net yet recognized	$ 9.9
Expected weighted average period for unrecognized compensation cost (in years)	1 year 8 months 12 days
Total fair value of share-based payment awards vested	$ 4.6	$ 11.2	$ 28.2

MARKETING AGREEMENT - Net Commission Earned Under the Marketing Agreement (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Marketing Agreement [Line Items]
Contribution expenses	$ (2,618.7)	$ (2,708.3)	$ (2,891.1)
Monsanto Marketing Agreement
Marketing Agreement [Line Items]
Gross commission	90.8	75.7	83.4
Contribution expenses	(18.0)	(18.0)	(18.0)
Net commission	72.8	57.7	65.4
Reimbursements associated with Roundup® marketing agreement	91.2	82.5	67.9
Total net sales associated with Roundup® marketing agreement	$ 164.0	$ 140.2	$ 133.3

SEGMENT INFORMATION - Net sales and long-lived assets by geographic area (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
Long-lived assets	704.4	723.1
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3,247.8	3,209.5	3,554.6
Long-lived assets	630.5	644.4
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	304.9	341.8	$ 369.5
Long-lived assets	$ 73.9	$ 78.7

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Consolidated Statements of Shareholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Shares	Capital in Excess of Stated Value	Retained Earnings	Treasury Shares	Accumulated Other Comprehensive Income (Loss)
Equity beginning balance (in shares) at Sep. 30, 2021		68.1
Equity beginning balance at Sep. 30, 2021		$ 0.3	$ 476.7	$ 1,605.1	$ (1,002.4)	$ (66.4)
Treasury shares, beginning balance (in shares) at Sep. 30, 2021					12.6
Total equity, beginning balance at Sep. 30, 2021	$ 1,013.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(437.5)			(437.5)
Other comprehensive income (loss)	(78.2)					(78.2)
Share-based compensation	30.3		30.3
Dividends declared	(147.5)			(147.5)
Treasury share purchases (in shares)					1.7
Treasury share purchases	(257.9)				$ (257.9)
Treasury share issuances (in shares)					(1.5)
Treasury share issuances	25.1		(143.3)		$ 168.4
Equity ending balance (in shares) at Sep. 30, 2022		68.1
Equity ending balance at Sep. 30, 2022		$ 0.3	363.7	1,020.1	$ (1,091.8)	(144.6)
Treasury shares, ending balance (in shares) at Sep. 30, 2022					12.8
Total equity, ending balance at Sep. 30, 2022	147.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(380.1)			(380.1)
Other comprehensive income (loss)	31.8					31.8
Share-based compensation	68.1		68.1
Dividends declared	(149.1)			(149.1)
Treasury share purchases (in shares)					0.1
Treasury share purchases	(9.3)				$ (9.3)
Treasury share issuances (in shares)					(1.3)
Treasury share issuances	23.7		(78.9)		$ 102.6
Equity ending balance (in shares) at Sep. 30, 2023		68.1
Equity ending balance at Sep. 30, 2023		$ 0.3	352.8	490.9	$ (998.5)	(112.8)
Treasury shares, ending balance (in shares) at Sep. 30, 2023					11.6
Total equity, ending balance at Sep. 30, 2023	(267.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(34.9)			(34.9)
Other comprehensive income (loss)	5.5					5.5
Share-based compensation	38.9		38.9
Dividends declared	(152.2)			(152.2)
Treasury share purchases (in shares)					0.1
Treasury share purchases	(5.1)				$ (5.1)
Treasury share issuances (in shares)					(0.7)
Treasury share issuances	24.5		(30.0)		$ 54.5
Equity ending balance (in shares) at Sep. 30, 2024		68.1
Equity ending balance at Sep. 30, 2024		$ 0.3	$ 361.7	$ 303.8	$ (949.1)	$ (107.3)
Treasury shares, ending balance (in shares) at Sep. 30, 2024					11.0
Total equity, ending balance at Sep. 30, 2024	$ (390.6)

SEGMENT INFORMATION - Net Sales by Product Category (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Revenue from External Customer [Line Items]
Net sales	$ 3,552.7	$ 3,551.3	$ 3,924.1
U.S. Consumer \| Growing media and mulch
Revenue from External Customer [Line Items]
Net sales	1,310.6	1,223.7	1,192.6
U.S. Consumer \| Lawn care
Revenue from External Customer [Line Items]
Net sales	929.6	897.4	973.6
U.S. Consumer \| Controls
Revenue from External Customer [Line Items]
Net sales	414.6	362.9	382.2
U.S. Consumer \| Roundup marketing agreement
Revenue from External Customer [Line Items]
Net sales	162.4	138.7	132.3
U.S. Consumer \| Other, primarily gardening
Revenue from External Customer [Line Items]
Net sales	196.5	221.0	248.1
Hawthorne
Revenue from External Customer [Line Items]
Net sales	294.7	467.3	716.2
Hawthorne \| Lighting
Revenue from External Customer [Line Items]
Net sales	108.2	165.9	200.0
Hawthorne \| Nutrients
Revenue from External Customer [Line Items]
Net sales	87.2	105.3	148.0
Hawthorne \| Growing environment
Revenue from External Customer [Line Items]
Net sales	27.7	72.5	143.7
Hawthorne \| Growing media
Revenue from External Customer [Line Items]
Net sales	37.3	67.5	119.0
Hawthorne \| Other, primarily hardware
Revenue from External Customer [Line Items]
Net sales	34.3	56.1	105.5
Other
Revenue from External Customer [Line Items]
Net sales	244.3	240.3	279.1
Other \| Lawn care
Revenue from External Customer [Line Items]
Net sales	80.2	75.8	92.9
Other \| Growing media
Revenue from External Customer [Line Items]
Net sales	91.3	93.0	96.6
Other \| Other, primarily gardening and controls
Revenue from External Customer [Line Items]
Net sales	$ 72.8	$ 71.5	$ 89.6